data_2amn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2amn _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.452 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 1.0 OUTLIER . . . . . 0 CA--C 1.53 0.209 0 CA-C-O 120.494 0.188 . . . . 0.0 110.544 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 6' ' ' TRP . 3.0 Cg_exo -75.61 -41.92 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.772 2.315 . . . . 0.0 113.591 -178.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.3 pp -98.93 -37.09 9.54 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.452 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 19.7 t -52.25 -59.5 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.905 0.384 . . . . 0.0 111.473 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.8 mt -58.87 -43.69 88.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.266 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.5 ttt180 -55.13 -20.59 10.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.809 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.7 p -82.59 -50.08 9.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.213 0.53 . . . . 0.0 109.596 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.8 t -65.71 -35.03 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.35 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.4 mm . . . . . 0 N--CA 1.45 -0.47 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.175 -179.776 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 t30 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.578 0.228 . . . . 0.0 111.505 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mt -94.85 -30.08 14.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.948 0.404 . . . . 0.0 110.586 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -124.31 -49.91 1.79 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.692 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -59.5 -43.65 93.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.059 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.19 -53.72 10.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.242 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.4 mm -50.7 -55.74 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.178 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.6 mttp -55.73 -25.05 38.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.224 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-O 120.891 0.377 . . . . 0.0 110.927 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.501 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 2.3 m0 . . . . . 0 CA--C 1.53 0.18 0 CA-C-O 120.52 0.2 . . . . 0.0 110.608 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 6' ' ' TRP . 7.5 Cg_exo -73.71 -40.51 1.43 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.739 2.293 . . . . 0.0 113.614 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.17 -36.55 8.9 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.501 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 20.6 t -55.68 -56.96 9.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.851 0.358 . . . . 0.0 111.272 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.428 HG12 ' HB2' ' A' ' 6' ' ' TRP . 36.8 mm -54.56 -43.67 65.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.915 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.64 -20.33 13.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.492 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.6 m -80.55 -53.14 6.84 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.5 t -62.01 -35.2 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.169 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.3 mm . . . . . 0 N--CA 1.449 -0.5 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.095 179.888 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.42 ' HA ' ' CB ' ' A' ' 22' ' ' ALA . 46.5 t30 . . . . . 0 CA--C 1.528 0.119 0 CA-C-O 120.596 0.236 . . . . 0.0 111.563 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 87.7 mt -104.71 24.02 12.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.002 0.43 . . . . 0.0 110.811 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -170.0 -59.96 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.304 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -64.56 -39.67 94.18 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.793 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.42 ' CB ' ' HA ' ' A' ' 18' ' ' ASN . . . -76.66 -44.2 34.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.6 mt -51.46 -54.73 10.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.115 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.2 pttm -55.08 -31.41 61.16 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.101 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.964 -179.912 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.468 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 2.9 m0 . . . . . 0 CA--C 1.53 0.191 0 CA-C-O 120.508 0.194 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -73.64 -39.82 1.76 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.894 2.396 . . . . 0.0 113.599 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.77 -38.68 9.38 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.468 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 21.0 t -53.89 -61.98 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.872 0.367 . . . . 0.0 111.259 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.1 mt -55.51 -40.01 56.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.986 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.88 -18.83 25.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.274 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.6 m -81.79 -51.51 8.07 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 39.5 t -59.94 -34.86 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.044 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.2 mt . . . . . 0 N--CA 1.452 -0.33 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.882 179.729 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 55.9 p30 . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.5 mt -104.6 -55.88 2.27 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.848 0.356 . . . . 0.0 110.534 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -56.53 -60.39 3.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.537 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.9 ttm180 -58.76 -52.11 67.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.059 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.47 -59.15 5.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.182 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.9 mt -51.44 -45.42 34.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.897 0.379 . . . . 0.0 110.954 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.24 -33.84 65.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.933 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.5 tttm . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 179.996 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.457 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 2.1 m0 . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.561 0.22 . . . . 0.0 110.7 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -72.41 -39.6 2.72 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.724 2.283 . . . . 0.0 113.807 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.74 -37.14 8.85 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.457 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 22.9 t -55.47 -58.23 5.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.867 0.365 . . . . 0.0 111.268 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.413 ' CG2' ' CD1' ' A' ' 14' ' ' ILE . 15.6 mt -64.01 -40.82 90.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.204 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -57.25 -21.06 31.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.613 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.15 -48.22 10.07 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.9 t -61.03 -34.1 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.997 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.413 ' CD1' ' CG2' ' A' ' 10' ' ' ILE . 43.2 mt . . . . . 0 N--CA 1.451 -0.391 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.135 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 120.613 0.244 . . . . 0.0 111.419 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.64 -21.22 30.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.811 0.339 . . . . 0.0 110.799 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -127.51 -54.91 1.34 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.651 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.68 -42.23 78.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.334 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.98 -50.54 11.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.289 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.5 mm -50.17 -52.54 14.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.421 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.1 pttm -53.39 -33.03 52.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.063 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.7 tptm . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.815 -179.874 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.437 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 5.3 m0 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.599 0.238 . . . . 0.0 110.69 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -87.04 -58.53 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.659 2.239 . . . . 0.0 113.751 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.78 -33.49 12.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.71 0.29 . . . . 0.0 111.428 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.437 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 22.0 t -49.31 -53.07 9.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.895 0.378 . . . . 0.0 111.536 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 29.7 mm -71.44 -46.41 64.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.082 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.6 tpt85 -51.71 -22.91 3.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.663 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.2 p -81.31 -50.52 9.41 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.1 t -63.41 -35.23 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.123 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.1 mm . . . . . 0 N--CA 1.453 -0.319 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.017 179.986 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.6 0.238 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.13 -17.49 32.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.869 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -131.84 -51.05 0.97 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.584 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -58.24 -43.5 87.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.857 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.93 -50.85 11.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.186 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.4 mm -50.48 -47.34 27.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.268 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.0 mmtm -53.89 -32.76 54.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.077 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.906 -179.924 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.513 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 3.5 m0 . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 120.761 0.315 . . . . 0.0 110.53 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -64.9 -35.81 42.39 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.988 2.459 . . . . 0.0 113.798 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.84 -38.73 8.93 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.513 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 42.0 t -55.72 -59.55 2.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.927 0.394 . . . . 0.0 111.26 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.413 HG12 ' HB2' ' A' ' 6' ' ' TRP . 42.4 mm -54.42 -38.62 41.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.191 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 11' ' ' ARG . 16.1 ttp-105 -55.97 -19.28 11.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.576 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.6 p -82.18 -51.34 8.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.334 0.587 . . . . 0.0 109.547 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.4 t -61.51 -34.99 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.286 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.8 mt . . . . . 0 N--CA 1.451 -0.383 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.016 -179.981 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.401 ' CA ' ' HB3' ' A' ' 22' ' ' ALA . 3.4 m-20 . . . . . 0 CA--C 1.529 0.158 0 N-CA-C 111.598 0.221 . . . . 0.0 111.598 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.441 ' CD1' ' CD2' ' A' ' 20' ' ' TYR . 0.9 OUTLIER -88.49 -19.56 26.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.854 0.359 . . . . 0.0 110.785 179.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.441 ' CD2' ' CD1' ' A' ' 19' ' ' LEU . 10.7 m-85 -129.48 -50.2 1.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.494 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.58 -45.34 94.53 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.28 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.401 ' HB3' ' CA ' ' A' ' 18' ' ' ASN . . . -72.75 -53.43 11.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.231 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.8 mt -53.83 -38.66 36.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.997 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.3 mmtm -57.19 -35.76 69.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.954 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.936 179.955 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.518 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 0.6 OUTLIER . . . . . 0 CA--C 1.53 0.18 0 CA-C-O 120.617 0.246 . . . . 0.0 110.595 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.53 -37.97 15.66 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.871 2.381 . . . . 0.0 113.938 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.99 -35.72 8.46 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.518 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 38.4 t -56.59 -51.39 66.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.86 0.362 . . . . 0.0 111.267 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.417 HG12 ' HB2' ' A' ' 6' ' ' TRP . 50.7 mm -57.97 -49.18 82.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.157 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.3 ttt-85 -52.92 -22.32 5.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.459 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.2 m -82.12 -49.89 9.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.316 0.579 . . . . 0.0 109.497 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.9 t -64.63 -35.43 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.234 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.4 mm . . . . . 0 N--CA 1.452 -0.326 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.842 179.806 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.721 0.296 . . . . 0.0 111.393 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 pp -90.32 -22.94 21.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.838 0.351 . . . . 0.0 110.679 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -121.81 -54.39 1.94 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.518 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -48.39 81.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.268 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.99 -56.06 13.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.357 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.6 mt -53.13 -48.29 53.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.907 0.384 . . . . 0.0 111.174 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -33.25 67.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.026 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.903 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.453 ' CE3' ' CG1' ' A' ' 9' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.575 0.226 . . . . 0.0 110.587 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -89.16 -58.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.598 2.199 . . . . 0.0 113.775 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.15 -30.63 15.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.74 0.305 . . . . 0.0 111.392 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.453 ' CG1' ' CE3' ' A' ' 6' ' ' TRP . 16.9 t -52.9 -59.15 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.265 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.42 HD12 ' CE3' ' A' ' 6' ' ' TRP . 28.7 mm -58.65 -48.55 85.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.994 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.23 -18.66 4.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.558 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.1 m -82.72 -49.36 9.85 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.1 t -62.96 -36.24 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.052 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 72.2 mt . . . . . 0 N--CA 1.451 -0.376 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.474 179.465 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.646 0.26 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 mt -92.54 18.58 8.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 110.994 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -157.07 -55.34 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.11 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.17 -45.6 66.38 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.754 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.26 -38.11 60.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.09 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.2 mm -52.37 -56.31 7.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.323 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.9 mmtm -51.92 -33.61 38.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.081 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.2 mttt . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 -179.905 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.502 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 1.1 m0 . . . . . 0 CA--C 1.53 0.186 0 CA-C-O 120.75 0.31 . . . . 0.0 110.706 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.85 -36.61 13.16 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.019 2.479 . . . . 0.0 113.582 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.77 -41.55 9.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.721 0.296 . . . . 0.0 111.485 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.502 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 39.7 t -52.7 -66.11 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.093 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.407 HG12 ' HB2' ' A' ' 6' ' ' TRP . 36.1 mm -55.98 -30.49 28.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.013 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.3 ttm-85 -54.39 -20.8 8.07 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.641 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.431 ' CG2' ' N ' ' A' ' 13' ' ' VAL . 1.3 t -82.51 -47.15 12.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.175 0.512 . . . . 0.0 109.714 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.431 ' N ' ' CG2' ' A' ' 12' ' ' THR . 26.4 t -62.64 -34.33 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.783 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.7 mt . . . . . 0 N--CA 1.449 -0.483 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.098 179.835 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 . . . . . 0 CA--C 1.53 0.179 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.8 pp -77.91 -21.24 51.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.853 0.358 . . . . 0.0 110.871 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -128.46 -51.89 1.27 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.956 0.407 . . . . 0.0 110.593 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.39 -42.72 87.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.065 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.64 -51.03 10.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.217 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.5 mm -49.91 -55.16 5.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.33 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -53.54 -30.21 40.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.158 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.3 ttpp . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 -179.905 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.47 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 3.6 m0 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.648 0.261 . . . . 0.0 110.607 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -86.33 -57.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.684 2.256 . . . . 0.0 113.85 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.56 -30.7 18.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.814 0.34 . . . . 0.0 111.278 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.47 ' HB ' ' HB3' ' A' ' 6' ' ' TRP . 12.8 t -55.39 -65.84 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 15.0 mt -59.21 -37.8 70.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.985 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.93 -22.28 3.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.588 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.2 p -78.46 -54.27 6.35 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.9 t -61.24 -34.99 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.11 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.8 mm . . . . . 0 N--CA 1.451 -0.384 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.925 -179.954 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 . . . . . 0 CA--C 1.528 0.111 0 CA-C-O 120.667 0.27 . . . . 0.0 111.407 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.4 mt -101.28 -32.87 10.29 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.937 0.398 . . . . 0.0 110.427 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -120.53 -49.14 2.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.252 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -48.63 80.94 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.874 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.94 -45.9 91.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.062 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.9 mm -51.4 -41.58 26.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.221 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.4 mtpt -54.16 -34.21 59.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.067 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.849 179.973 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.473 ' CD1' ' N ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.793 0.33 . . . . 0.0 110.741 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -63.48 -35.57 59.68 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 123.053 2.502 . . . . 0.0 113.442 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 pp -94.19 -42.2 9.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.901 0.381 . . . . 0.0 111.386 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.467 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 19.5 t -54.3 -59.65 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.091 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 62.9 mt -56.03 -40.73 65.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.972 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.46 -18.33 27.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.374 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.7 m -82.36 -51.55 7.76 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.7 t -58.65 -34.59 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.94 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.1 mt . . . . . 0 N--CA 1.451 -0.423 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.847 179.665 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.5 m120 . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.77 0.319 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.1 mt -58.09 -19.92 35.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.252 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -114.82 -62.29 1.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.921 0.391 . . . . 0.0 110.814 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -49.54 75.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.441 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.41 -52.5 15.67 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.391 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.5 mm -54.85 -53.17 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.972 0.415 . . . . 0.0 111.1 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.92 -29.13 62.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.04 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.3 mmtt . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.904 179.957 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.467 ' CE3' ' CG1' ' A' ' 9' ' ' VAL . 2.8 m0 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.587 0.232 . . . . 0.0 110.821 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -89.73 -57.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.812 2.341 . . . . 0.0 113.885 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.1 pp -92.48 -31.53 15.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.746 0.308 . . . . 0.0 111.469 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.467 ' CG1' ' CE3' ' A' ' 6' ' ' TRP . 18.5 t -53.22 -60.19 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.314 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.445 HD11 HG22 ' A' ' 10' ' ' ILE . 36.5 mm -63.89 -34.95 71.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.795 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.57 -20.12 7.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.421 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -80.67 -52.0 8.05 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.2 t -59.03 -34.69 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.084 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 30.9 mt . . . . . 0 N--CA 1.452 -0.342 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.84 179.768 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.5 t30 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.684 0.278 . . . . 0.0 111.486 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.9 mt -85.38 -25.36 27.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.217 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.5 27.18 7.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.957 0.408 . . . . 0.0 111.077 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 16.1 ttp85 -146.69 -48.18 0.19 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.267 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.77 -34.4 34.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.113 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.5 mm -57.26 -57.55 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.002 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.72 -30.63 33.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.139 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.88 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.474 ' CD1' ' N ' ' A' ' 6' ' ' TRP . 0.9 OUTLIER . . . . . 0 CA--C 1.531 0.225 0 CA-C-O 120.542 0.211 . . . . 0.0 110.609 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -83.14 -57.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.578 2.185 . . . . 0.0 114.067 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.76 -31.22 18.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.761 0.315 . . . . 0.0 111.351 -178.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.453 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 18.8 t -52.92 -65.77 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.319 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.1 mt -56.9 -41.03 75.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.236 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.65 -21.3 10.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.7 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.1 p -83.54 -48.25 10.46 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.8 t -62.95 -35.0 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.155 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.8 mm . . . . . 0 N--CA 1.45 -0.46 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.087 179.942 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 48.3 t30 . . . . . 0 CA--C 1.528 0.13 0 CA-C-O 120.583 0.23 . . . . 0.0 111.47 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.1 mt -101.63 -26.6 13.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.859 0.361 . . . . 0.0 110.63 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.87 -55.69 2.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.555 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -48.77 80.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.134 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.08 -48.45 81.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.256 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.1 mm -51.47 -48.12 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.239 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.07 -33.3 51.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.182 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 179.984 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.474 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 1.4 m0 . . . . . 0 CA--C 1.531 0.212 0 CA-C-O 120.498 0.19 . . . . 0.0 110.699 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.62 -40.27 1.57 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.815 2.343 . . . . 0.0 113.687 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.12 -37.76 9.59 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.474 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 19.3 t -54.47 -61.46 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.873 0.368 . . . . 0.0 111.423 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 16.1 mt -57.39 -38.57 63.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.129 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -19.53 10.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.518 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.2 p -83.28 -49.86 8.97 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.9 t -60.94 -34.72 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.267 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.2 mt . . . . . 0 N--CA 1.451 -0.379 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.962 179.965 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.3 m120 . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 120.825 0.345 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.9 mt -59.45 -19.66 49.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.065 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -125.71 -55.72 1.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.727 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.14 -33.88 69.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.419 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.36 -47.68 7.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.335 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.9 mm -55.86 -40.12 60.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.963 0.411 . . . . 0.0 111.104 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -56.14 -34.83 66.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.023 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.7 mtpp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.927 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.459 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 1.8 m0 . . . . . 0 CA--C 1.529 0.155 0 CA-C-O 120.64 0.257 . . . . 0.0 110.664 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -70.88 -38.85 4.87 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.884 2.389 . . . . 0.0 113.775 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.57 -37.91 9.36 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.459 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 21.3 t -54.15 -61.39 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.999 0.428 . . . . 0.0 111.235 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 18.8 mt -55.57 -41.33 63.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.002 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.9 ttt85 -59.28 -17.44 28.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.301 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.28 -50.04 8.79 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 39.4 t -59.9 -34.85 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.982 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 68.3 mt . . . . . 0 N--CA 1.449 -0.511 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.927 179.813 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.53 0.199 0 CA-C-O 120.471 0.177 . . . . 0.0 111.342 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 mt -84.15 -30.69 25.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.95 0.405 . . . . 0.0 110.597 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -118.39 -52.02 2.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.587 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.42 -48.64 74.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.134 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.6 -53.91 14.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.936 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.0 mm -53.72 -44.79 60.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.095 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -56.73 -35.5 68.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.002 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.944 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.5 ' CD1' ' N ' ' A' ' 6' ' ' TRP . 2.2 m0 . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 120.538 0.208 . . . . 0.0 110.668 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -88.37 -57.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.679 2.253 . . . . 0.0 113.828 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.02 -33.93 15.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.801 0.334 . . . . 0.0 111.28 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.482 ' HB ' ' HB3' ' A' ' 6' ' ' TRP . 21.5 t -51.45 -62.57 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.377 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 30.5 mt -61.18 -34.54 60.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.839 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -52.1 -21.94 3.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.463 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.1 m -79.29 -52.52 8.01 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.8 t -60.35 -34.63 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.951 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.1 mt . . . . . 0 N--CA 1.453 -0.323 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.799 179.873 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.672 0.272 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 12.3 mt -53.29 -23.22 8.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.177 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -126.1 -56.86 1.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.338 . . . . 0.0 110.797 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.51 -32.87 67.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.379 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.25 -48.38 7.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.397 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.1 mm -53.39 -41.7 45.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.189 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.4 -31.51 61.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.029 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.994 -179.993 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.433 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 3.8 m0 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.521 0.2 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 6' ' ' TRP . 68.2 Cg_endo -90.2 -57.22 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.792 2.328 . . . . 0.0 113.721 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.12 -31.87 17.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.822 0.344 . . . . 0.0 111.308 -179.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.433 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 17.6 t -52.86 -65.59 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.282 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.5 mt -59.49 -38.31 74.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.15 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -55.85 -19.85 13.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.505 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -81.16 -51.92 7.91 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.8 t -59.26 -34.47 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.02 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.0 mt . . . . . 0 N--CA 1.451 -0.386 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.002 179.863 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.785 0.326 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.7 mt -57.9 -20.81 39.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.304 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.416 ' CZ ' ' HE3' ' A' ' 24' ' ' LYS . 1.5 t80 -115.99 -65.69 1.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.372 . . . . 0.0 110.913 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.73 -45.1 74.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.553 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.81 -53.21 10.77 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.274 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.1 mm -55.37 -50.61 64.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.007 0.432 . . . . 0.0 111.128 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.416 ' HE3' ' CZ ' ' A' ' 20' ' ' TYR . 24.6 mmtt -58.21 -30.48 66.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.069 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.3 mttp . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.917 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.475 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 1.6 m0 . . . . . 0 CA--C 1.531 0.231 0 CA-C-O 120.507 0.194 . . . . 0.0 110.628 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 6' ' ' TRP . 7.3 Cg_exo -73.58 -42.03 0.98 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.693 2.262 . . . . 0.0 113.748 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.64 -34.91 9.3 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.475 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 20.2 t -54.04 -55.21 15.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.974 0.416 . . . . 0.0 111.447 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 mt -68.91 -44.81 81.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.27 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.52 -22.47 8.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.859 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.8 p -82.38 -49.58 9.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -64.38 -35.13 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.113 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.3 mm . . . . . 0 N--CA 1.45 -0.444 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.101 179.925 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.577 0.227 . . . . 0.0 111.367 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mt -97.84 25.85 5.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.879 0.371 . . . . 0.0 110.675 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -163.34 -59.88 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.224 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -43.3 74.93 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.995 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.94 -49.27 25.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.246 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.3 mt -51.51 -59.97 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.009 0.433 . . . . 0.0 111.131 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -53.46 -25.31 15.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.171 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.937 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.45 ' CE3' ' CG1' ' A' ' 9' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.621 0.248 . . . . 0.0 110.695 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -89.12 -58.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.783 2.322 . . . . 0.0 113.944 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.58 -34.02 13.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.768 0.318 . . . . 0.0 111.293 -179.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.45 ' CG1' ' CE3' ' A' ' 6' ' ' TRP . 39.8 t -49.79 -57.4 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.558 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 78.2 mt -65.74 -44.46 93.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.147 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.88 -21.58 3.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.649 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.47 -50.27 9.62 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.0 t -61.91 -35.24 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.947 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 51.6 mt . . . . . 0 N--CA 1.454 -0.271 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.739 179.784 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 120.59 0.233 . . . . 0.0 111.356 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.6 mt -85.06 -17.98 35.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.797 0.332 . . . . 0.0 111.325 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -123.84 -59.18 1.53 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.835 0.35 . . . . 0.0 110.81 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.67 -45.15 73.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.39 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.72 -52.03 11.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.068 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.6 mm -51.82 -41.63 30.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.172 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -55.18 -34.56 63.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.091 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.916 -179.982 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.458 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 1.9 m0 . . . . . 0 CA--C 1.528 0.105 0 CA-C-O 120.562 0.22 . . . . 0.0 110.59 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -89.54 -58.57 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.684 2.256 . . . . 0.0 113.684 -179.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 pp -93.09 -30.94 15.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.791 0.329 . . . . 0.0 111.372 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.458 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 21.3 t -50.08 -57.98 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.427 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.418 ' CG2' ' CD1' ' A' ' 14' ' ' ILE . 23.0 mt -66.55 -40.14 85.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.244 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.3 tpt85 -56.33 -20.09 17.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.653 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.4 p -82.94 -49.71 9.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.347 0.594 . . . . 0.0 109.451 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.2 t -60.81 -34.64 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.138 178.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.418 ' CD1' ' CG2' ' A' ' 10' ' ' ILE . 43.5 mt . . . . . 0 N--CA 1.449 -0.487 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.265 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.408 ' HB2' ' HA ' ' A' ' 14' ' ' ILE . 1.4 m-20 . . . . . 0 CA--C 1.529 0.161 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 mt -79.96 -9.71 59.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.712 0.291 . . . . 0.0 111.029 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.98 -60.24 0.97 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.886 0.374 . . . . 0.0 110.634 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -43.4 83.2 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.238 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.406 ' HB3' ' CA ' ' A' ' 18' ' ' ASN . . . -76.27 -50.9 13.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.217 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.0 mm -47.5 -62.9 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.34 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -53.63 -30.31 42.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.013 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.788 0.327 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.1 m -71.16 157.44 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.145 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.1 -30.3 7.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.912 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -167.49 111.01 0.67 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.843 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.423 ' CG1' ' CD1' ' A' ' 6' ' ' TRP . 2.7 t -106.59 -68.61 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.078 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.452 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 1.0 OUTLIER -111.29 111.18 55.6 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.544 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 6' ' ' TRP . 3.0 Cg_exo -75.61 -41.92 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.772 2.315 . . . . 0.0 113.591 -178.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.3 pp -98.93 -37.09 9.54 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.452 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 19.7 t -52.25 -59.5 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.905 0.384 . . . . 0.0 111.473 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.8 mt -58.87 -43.69 88.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.266 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.5 ttt180 -55.13 -20.59 10.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.809 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.7 p -82.59 -50.08 9.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.213 0.53 . . . . 0.0 109.596 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.8 t -65.71 -35.03 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.35 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.4 mm -77.02 -41.68 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.175 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.34 0.7 40.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.618 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.1 -19.25 4.38 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.922 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -147.63 13.79 1.06 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.838 0.319 . . . . 0.0 111.769 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -136.11 4.9 3.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.578 0.228 . . . . 0.0 111.505 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mt -94.85 -30.08 14.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.948 0.404 . . . . 0.0 110.586 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -124.31 -49.91 1.79 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.692 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -59.5 -43.65 93.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.059 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.19 -53.72 10.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.242 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.4 mm -50.7 -55.74 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.178 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.6 mttp -55.73 -25.05 38.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.224 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.06 41.1 1.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.891 0.377 . . . . 0.0 110.927 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.881 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.748 0.309 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.2 t -116.68 159.37 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.043 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.0 mtpt -58.67 151.94 19.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.49 115.14 27.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.945 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.5 -59.71 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.039 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.501 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 2.3 m0 -77.12 121.87 85.36 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.608 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 6' ' ' TRP . 7.5 Cg_exo -73.71 -40.51 1.43 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.739 2.293 . . . . 0.0 113.614 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.17 -36.55 8.9 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.501 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 20.6 t -55.68 -56.96 9.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.851 0.358 . . . . 0.0 111.272 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.428 HG12 ' HB2' ' A' ' 6' ' ' TRP . 36.8 mm -54.56 -43.67 65.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.915 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.64 -20.33 13.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.492 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.6 m -80.55 -53.14 6.84 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.5 t -62.01 -35.2 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.169 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.3 mm -74.98 -38.22 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.095 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.07 -17.47 62.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.389 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.07 13.41 19.49 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.756 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -114.28 -69.6 0.85 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.973 0.416 . . . . 0.0 110.989 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.42 ' HA ' ' CB ' ' A' ' 22' ' ' ALA . 46.5 t30 -72.47 -9.95 59.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.563 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 87.7 mt -104.71 24.02 12.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.002 0.43 . . . . 0.0 110.811 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -170.0 -59.96 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.304 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -64.56 -39.67 94.18 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.793 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.42 ' CB ' ' HA ' ' A' ' 18' ' ' ASN . . . -76.66 -44.2 34.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.6 mt -51.46 -54.73 10.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.115 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.2 pttm -55.08 -31.41 61.16 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.101 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -71.7 -33.42 68.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.964 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.0 pttt . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.921 179.924 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.744 0.307 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.4 m -98.27 84.91 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.009 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.6 ptmm? -116.33 148.18 40.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.968 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -169.07 143.16 2.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.809 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -129.9 -62.99 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.251 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.468 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 2.9 m0 -90.87 110.33 41.04 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.798 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -73.64 -39.82 1.76 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.894 2.396 . . . . 0.0 113.599 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.77 -38.68 9.38 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.468 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 21.0 t -53.89 -61.98 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.872 0.367 . . . . 0.0 111.259 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.1 mt -55.51 -40.01 56.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.986 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.88 -18.83 25.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.274 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.6 m -81.79 -51.51 8.07 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 39.5 t -59.94 -34.86 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.044 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.2 mt -64.35 -44.7 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.882 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.27 -31.92 67.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.924 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.35 -4.53 64.25 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.775 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -106.03 -37.53 6.6 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.887 0.375 . . . . 0.0 110.726 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 55.9 p30 -83.59 7.6 16.78 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.539 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.5 mt -104.6 -55.88 2.27 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.848 0.356 . . . . 0.0 110.534 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -56.53 -60.39 3.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.537 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.9 ttm180 -58.76 -52.11 67.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.059 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.47 -59.15 5.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.182 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.9 mt -51.44 -45.42 34.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.897 0.379 . . . . 0.0 110.954 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.24 -33.84 65.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.933 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.5 tttm -68.75 98.96 0.96 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.148 -0.929 . . . . 0.0 110.926 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.83 0.348 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.46 -51.11 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.106 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.4 tttp 59.78 78.56 0.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.782 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -102.07 160.05 14.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.954 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.36 -170.78 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.679 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.457 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 2.1 m0 -70.55 110.16 6.43 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.7 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -72.41 -39.6 2.72 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.724 2.283 . . . . 0.0 113.807 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.74 -37.14 8.85 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.457 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 22.9 t -55.47 -58.23 5.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.867 0.365 . . . . 0.0 111.268 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.413 ' CG2' ' CD1' ' A' ' 14' ' ' ILE . 15.6 mt -64.01 -40.82 90.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.204 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -57.25 -21.06 31.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.613 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.15 -48.22 10.07 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.9 t -61.03 -34.1 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.997 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.413 ' CD1' ' CG2' ' A' ' 10' ' ' ILE . 43.2 mt -70.97 -39.72 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.135 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.26 3.96 40.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.664 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -133.76 -10.85 1.75 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.594 -0.813 . . . . 0.0 113.297 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -128.09 -31.63 2.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.012 0.406 . . . . 0.0 111.463 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 -90.39 19.8 4.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.419 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.64 -21.22 30.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.811 0.339 . . . . 0.0 110.799 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -127.51 -54.91 1.34 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.651 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.68 -42.23 78.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.334 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.98 -50.54 11.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.289 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.5 mm -50.17 -52.54 14.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.421 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.1 pttm -53.39 -33.03 52.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.063 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -88.58 98.37 11.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.815 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.8 mttt . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.887 -179.966 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 4.1 mtp85 . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.938 0.399 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.9 p -176.41 138.51 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.067 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -125.67 30.57 5.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.941 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 63.03 143.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.117 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -103.22 -163.5 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.544 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.437 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 5.3 m0 -55.37 146.09 44.33 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-O 120.599 0.238 . . . . 0.0 110.69 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -87.04 -58.53 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.659 2.239 . . . . 0.0 113.751 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.78 -33.49 12.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.71 0.29 . . . . 0.0 111.428 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.437 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 22.0 t -49.31 -53.07 9.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.895 0.378 . . . . 0.0 111.536 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 29.7 mm -71.44 -46.41 64.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.082 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.6 tpt85 -51.71 -22.91 3.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.663 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.2 p -81.31 -50.52 9.41 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.1 t -63.41 -35.23 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.123 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.1 mm -68.33 -43.89 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.017 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.51 -11.77 61.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.663 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.51 -13.62 16.43 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.04 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.6 -35.9 3.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.875 0.338 . . . . 0.0 111.275 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -94.74 21.23 7.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.274 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.13 -17.49 32.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.869 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -131.84 -51.05 0.97 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.584 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -58.24 -43.5 87.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.857 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.93 -50.85 11.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.186 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.4 mm -50.48 -47.34 27.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.268 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.0 mmtm -53.89 -32.76 54.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.077 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -107.78 51.02 0.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.906 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.148 -0.929 . . . . 0.0 110.84 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.803 0.335 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.9 m -131.62 144.86 36.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.072 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -161.08 133.88 6.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.963 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 -106.51 -70.99 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.678 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.434 HG12 ' CD1' ' A' ' 6' ' ' TRP . 3.3 t -149.45 -73.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.513 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 3.5 m0 -111.04 99.31 42.54 Favored Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.53 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -64.9 -35.81 42.39 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.988 2.459 . . . . 0.0 113.798 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.84 -38.73 8.93 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.513 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 42.0 t -55.72 -59.55 2.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.927 0.394 . . . . 0.0 111.26 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.413 HG12 ' HB2' ' A' ' 6' ' ' TRP . 42.4 mm -54.42 -38.62 41.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.191 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 11' ' ' ARG . 16.1 ttp-105 -55.97 -19.28 11.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.576 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.6 p -82.18 -51.34 8.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.334 0.587 . . . . 0.0 109.547 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.4 t -61.51 -34.99 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.286 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.8 mt -66.29 -38.46 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.016 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.26 -3.83 44.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.574 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -139.96 19.95 2.89 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.941 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -155.41 -33.98 0.09 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.576 0.227 . . . . 0.0 111.481 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.401 ' CA ' ' HB3' ' A' ' 22' ' ' ALA . 3.4 m-20 -87.08 16.42 5.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.598 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.441 ' CD1' ' CD2' ' A' ' 20' ' ' TYR . 0.9 OUTLIER -88.49 -19.56 26.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.854 0.359 . . . . 0.0 110.785 179.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.441 ' CD2' ' CD1' ' A' ' 19' ' ' LEU . 10.7 m-85 -129.48 -50.2 1.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.494 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.58 -45.34 94.53 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.28 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.401 ' HB3' ' CA ' ' A' ' 18' ' ' ASN . . . -72.75 -53.43 11.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.231 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.8 mt -53.83 -38.66 36.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.997 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.3 mmtm -57.19 -35.76 69.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.954 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -69.74 92.11 0.66 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.936 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.2 mttp . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.955 -179.999 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.78 0.324 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.2 p -136.49 -45.15 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.157 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.12 -178.16 3.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.908 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -88.17 85.74 6.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.825 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.8 t -141.15 156.49 21.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.959 0.409 . . . . 0.0 111.137 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.518 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 0.6 OUTLIER -112.48 107.36 55.25 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.595 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.53 -37.97 15.66 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.871 2.381 . . . . 0.0 113.938 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.99 -35.72 8.46 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.518 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 38.4 t -56.59 -51.39 66.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.86 0.362 . . . . 0.0 111.267 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.417 HG12 ' HB2' ' A' ' 6' ' ' TRP . 50.7 mm -57.97 -49.18 82.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.157 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.3 ttt-85 -52.92 -22.32 5.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.459 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.2 m -82.12 -49.89 9.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.316 0.579 . . . . 0.0 109.497 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.9 t -64.63 -35.43 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.234 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.4 mm -64.92 -39.43 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.842 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.04 -21.98 66.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.238 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -107.57 8.48 37.41 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.895 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -121.45 -37.94 2.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.832 0.349 . . . . 0.0 111.212 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -95.15 20.1 9.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.393 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 pp -90.32 -22.94 21.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.838 0.351 . . . . 0.0 110.679 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -121.81 -54.39 1.94 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.518 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -48.39 81.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.268 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.99 -56.06 13.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.357 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.6 mt -53.13 -48.29 53.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.907 0.384 . . . . 0.0 111.174 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -33.25 67.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.026 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.24 -36.12 79.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.903 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.2 mmmt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.898 -179.98 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 120.85 0.357 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.9 p -91.76 158.97 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.08 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 66.66 92.59 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 62.17 116.77 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.986 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.0 t -99.46 -67.93 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.913 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.453 ' CE3' ' CG1' ' A' ' 9' ' ' VAL . 1.0 OUTLIER -103.73 145.62 30.97 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.587 179.776 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -89.16 -58.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.598 2.199 . . . . 0.0 113.775 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.15 -30.63 15.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.74 0.305 . . . . 0.0 111.392 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.453 ' CG1' ' CE3' ' A' ' 6' ' ' TRP . 16.9 t -52.9 -59.15 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.265 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.42 HD12 ' CE3' ' A' ' 6' ' ' TRP . 28.7 mm -58.65 -48.55 85.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.994 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.23 -18.66 4.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.558 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.1 m -82.72 -49.36 9.85 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.1 t -62.96 -36.24 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.052 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 72.2 mt -61.8 -38.85 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.474 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.8 -22.33 66.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.145 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.49 -2.65 22.8 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.231 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.16 1.6 6.46 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.995 0.397 . . . . 0.0 111.636 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -142.04 -43.29 0.34 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.646 0.26 . . . . 0.0 111.423 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 mt -92.54 18.58 8.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 110.994 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -157.07 -55.34 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.11 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.17 -45.6 66.38 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.754 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.26 -38.11 60.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.09 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.2 mm -52.37 -56.31 7.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.323 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.9 mmtm -51.92 -33.61 38.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.081 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -78.93 95.97 5.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.903 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.6 mtm105 . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.812 0.339 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.4 t 61.92 80.7 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.193 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.0 118.23 0.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.787 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.02 155.19 46.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.917 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -90.2 -163.9 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.374 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.502 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 1.1 m0 -108.99 99.75 36.84 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 120.75 0.31 . . . . 0.0 110.706 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.85 -36.61 13.16 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.019 2.479 . . . . 0.0 113.582 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.77 -41.55 9.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.721 0.296 . . . . 0.0 111.485 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.502 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 39.7 t -52.7 -66.11 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.093 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.407 HG12 ' HB2' ' A' ' 6' ' ' TRP . 36.1 mm -55.98 -30.49 28.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.013 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.3 ttm-85 -54.39 -20.8 8.07 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.641 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.431 ' CG2' ' N ' ' A' ' 13' ' ' VAL . 1.3 t -82.51 -47.15 12.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.175 0.512 . . . . 0.0 109.714 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.431 ' N ' ' CG2' ' A' ' 12' ' ' THR . 26.4 t -62.64 -34.33 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.783 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.7 mt -70.55 -53.57 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.098 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.4 -25.88 68.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.259 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.29 -8.12 66.73 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.955 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -115.06 -35.7 4.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.853 0.358 . . . . 0.0 111.125 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -81.52 0.37 38.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.628 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.8 pp -77.91 -21.24 51.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.853 0.358 . . . . 0.0 110.871 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -128.46 -51.89 1.27 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.956 0.407 . . . . 0.0 110.593 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.39 -42.72 87.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.065 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.64 -51.03 10.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.217 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.5 mm -49.91 -55.16 5.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.33 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -53.54 -30.21 40.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.158 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.3 ttpp -91.34 49.89 1.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.1 mttt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.914 179.95 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.891 0.377 . . . . 0.0 111.173 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.0 p -138.1 105.3 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.19 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -77.87 149.28 34.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.851 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.38 122.59 45.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.063 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -92.01 -167.76 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.546 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.47 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 3.6 m0 -77.73 129.28 77.07 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.648 0.261 . . . . 0.0 110.607 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -86.33 -57.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.684 2.256 . . . . 0.0 113.85 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.56 -30.7 18.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.814 0.34 . . . . 0.0 111.278 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.47 ' HB ' ' HB3' ' A' ' 6' ' ' TRP . 12.8 t -55.39 -65.84 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 15.0 mt -59.21 -37.8 70.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.985 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.93 -22.28 3.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.588 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.2 p -78.46 -54.27 6.35 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.9 t -61.24 -34.99 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.11 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.8 mm -68.49 -39.07 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.925 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.25 -6.8 58.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.512 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -121.13 -7.55 8.4 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.045 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -143.44 10.83 1.68 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.887 0.344 . . . . 0.0 111.642 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -137.28 8.75 2.93 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.667 0.27 . . . . 0.0 111.407 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.4 mt -101.28 -32.87 10.29 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.937 0.398 . . . . 0.0 110.427 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -120.53 -49.14 2.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.252 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -48.63 80.94 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.874 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.94 -45.9 91.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.062 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.9 mm -51.4 -41.58 26.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.221 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.4 mtpt -54.16 -34.21 59.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.067 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -77.97 64.2 3.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.849 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.4 mttt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.862 -179.977 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.852 0.358 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.4 m -96.38 -179.6 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.117 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -148.33 122.2 9.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.777 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -58.04 -62.28 1.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.892 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 t -85.38 153.36 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.745 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.473 ' CD1' ' N ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -118.04 82.85 18.17 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.741 -179.744 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -63.48 -35.57 59.68 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 123.053 2.502 . . . . 0.0 113.442 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 pp -94.19 -42.2 9.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.901 0.381 . . . . 0.0 111.386 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.467 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 19.5 t -54.3 -59.65 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.091 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 62.9 mt -56.03 -40.73 65.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.972 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.46 -18.33 27.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.374 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.7 m -82.36 -51.55 7.76 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.7 t -58.65 -34.59 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.94 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.73 -53.7 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.847 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.75 -20.76 63.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.325 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.7 -20.78 53.15 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.989 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.6 -38.9 5.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.847 0.356 . . . . 0.0 111.192 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -66.61 -25.7 66.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.028 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.1 mt -58.09 -19.92 35.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.252 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -114.82 -62.29 1.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.921 0.391 . . . . 0.0 110.814 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -49.54 75.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.441 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.41 -52.5 15.67 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.391 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.5 mm -54.85 -53.17 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.972 0.415 . . . . 0.0 111.1 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.92 -29.13 62.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.04 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.3 mmtt -85.76 85.57 7.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.904 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.0 tttt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.875 179.966 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.773 0.321 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -117.22 -38.78 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.165 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.99 -172.68 4.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.899 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.12 149.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.974 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.55 -62.87 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.159 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.467 ' CE3' ' CG1' ' A' ' 9' ' ' VAL . 2.8 m0 -69.34 149.57 97.31 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.821 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -89.73 -57.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.812 2.341 . . . . 0.0 113.885 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.1 pp -92.48 -31.53 15.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.746 0.308 . . . . 0.0 111.469 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.467 ' CG1' ' CE3' ' A' ' 6' ' ' TRP . 18.5 t -53.22 -60.19 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.314 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.445 HD11 HG22 ' A' ' 10' ' ' ILE . 36.5 mm -63.89 -34.95 71.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.795 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.57 -20.12 7.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.421 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -80.67 -52.0 8.05 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.2 t -59.03 -34.69 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.084 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 30.9 mt -70.01 -40.08 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.84 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.53 -33.7 76.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.034 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.02 -8.51 78.85 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.698 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.423 ' CE2' ' HD3' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -98.31 -65.66 0.95 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.927 0.394 . . . . 0.0 110.974 -179.903 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -55.0 -23.35 18.9 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.486 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.9 mt -85.38 -25.36 27.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.217 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.5 27.18 7.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.957 0.408 . . . . 0.0 111.077 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.423 ' HD3' ' CE2' ' A' ' 17' ' ' TYR . 16.1 ttp85 -146.69 -48.18 0.19 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.267 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.77 -34.4 34.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.113 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.5 mm -57.26 -57.55 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.002 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.72 -30.63 33.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.139 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.05 93.51 5.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.88 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.9 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.826 0.346 . . . . 0.0 111.162 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.4 m -132.84 -44.87 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.159 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.09 122.5 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.816 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 34.2 mtp180 -143.2 92.61 2.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.976 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 t -71.61 155.97 7.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.948 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.474 ' CD1' ' N ' ' A' ' 6' ' ' TRP . 0.9 OUTLIER -111.25 123.3 35.46 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.609 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -83.14 -57.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.578 2.185 . . . . 0.0 114.067 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.76 -31.22 18.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.761 0.315 . . . . 0.0 111.351 -178.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.453 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 18.8 t -52.92 -65.77 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.319 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.1 mt -56.9 -41.03 75.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.236 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.65 -21.3 10.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.7 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.1 p -83.54 -48.25 10.46 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.8 t -62.95 -35.0 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.155 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.8 mm -76.17 -38.59 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.087 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.05 -13.97 60.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.44 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.75 -23.19 8.89 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.774 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -97.73 -44.12 6.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.829 0.347 . . . . 0.0 110.997 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -75.2 -7.24 53.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.47 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.1 mt -101.63 -26.6 13.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.859 0.361 . . . . 0.0 110.63 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.87 -55.69 2.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.555 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -48.77 80.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.134 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.08 -48.45 81.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.256 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.1 mm -51.47 -48.12 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.239 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.07 -33.3 51.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.182 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -84.75 -32.79 23.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.6 mttm . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.299 -0.858 . . . . 0.0 110.875 -179.868 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.922 0.391 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.4 t -119.25 110.99 31.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.112 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 68.68 -67.38 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.995 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -110.95 156.15 21.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.944 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.12 -60.92 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.118 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.474 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 1.4 m0 -86.68 110.86 35.56 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.699 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.62 -40.27 1.57 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.815 2.343 . . . . 0.0 113.687 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.12 -37.76 9.59 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.474 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 19.3 t -54.47 -61.46 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.873 0.368 . . . . 0.0 111.423 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 16.1 mt -57.39 -38.57 63.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.129 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -19.53 10.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.518 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.2 p -83.28 -49.86 8.97 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.9 t -60.94 -34.72 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.267 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 96.2 mt -66.57 -39.86 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.962 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.0 -0.29 43.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.572 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.25 -13.44 7.61 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.826 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -107.68 -39.67 5.53 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.766 0.317 . . . . 0.0 110.862 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -61.28 -28.2 69.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.855 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.9 mt -59.45 -19.66 49.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.065 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -125.71 -55.72 1.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.727 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.14 -33.88 69.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.419 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.36 -47.68 7.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.335 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.9 mm -55.86 -40.12 60.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.963 0.411 . . . . 0.0 111.104 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -56.14 -34.83 66.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.023 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.7 mtpp -99.89 33.47 2.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.946 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 29.5 ptt85 . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.875 0.369 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.3 t -60.77 149.49 7.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.15 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -104.32 177.47 4.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.752 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.62 -73.19 0.61 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.916 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.6 t -151.99 -65.46 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.089 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.459 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 1.8 m0 -105.65 104.33 47.92 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.664 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -70.88 -38.85 4.87 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.884 2.389 . . . . 0.0 113.775 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.57 -37.91 9.36 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.459 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 21.3 t -54.15 -61.39 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.999 0.428 . . . . 0.0 111.235 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 18.8 mt -55.57 -41.33 63.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.002 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.9 ttt85 -59.28 -17.44 28.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.301 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.28 -50.04 8.79 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 39.4 t -59.9 -34.85 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.982 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 68.3 mt -77.89 -37.58 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.927 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.84 9.7 18.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.456 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -133.52 -11.92 1.65 Allowed Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.56 -0.829 . . . . 0.0 113.311 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -128.96 -26.96 2.57 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 117.113 0.457 . . . . 0.0 111.437 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -88.9 15.14 8.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.342 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 mt -84.15 -30.69 25.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.95 0.405 . . . . 0.0 110.597 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -118.39 -52.02 2.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.587 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.42 -48.64 74.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.134 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.6 -53.91 14.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.936 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.0 mm -53.72 -44.79 60.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.095 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -56.73 -35.5 68.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.002 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.43 96.83 10.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.944 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.8 ttpt . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.997 179.936 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.843 0.354 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.4 t -117.13 102.5 13.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.138 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -115.51 163.77 15.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.751 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -168.16 107.88 0.53 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.047 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.3 t -83.87 174.19 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.577 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.5 ' CD1' ' N ' ' A' ' 6' ' ' TRP . 2.2 m0 -80.11 132.05 61.07 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.668 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -88.37 -57.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.679 2.253 . . . . 0.0 113.828 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.02 -33.93 15.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.801 0.334 . . . . 0.0 111.28 -179.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.482 ' HB ' ' HB3' ' A' ' 6' ' ' TRP . 21.5 t -51.45 -62.57 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.377 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 30.5 mt -61.18 -34.54 60.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.839 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -52.1 -21.94 3.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.463 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.1 m -79.29 -52.52 8.01 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.8 t -60.35 -34.63 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.951 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.1 mt -61.14 -43.45 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.799 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.31 -0.43 28.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.7 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.08 -13.63 6.39 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.152 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.76 -51.75 0.74 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.86 0.33 . . . . 0.0 111.353 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -58.41 -20.79 47.35 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.268 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 12.3 mt -53.29 -23.22 8.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.177 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -126.1 -56.86 1.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.338 . . . . 0.0 110.797 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.51 -32.87 67.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.379 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.25 -48.38 7.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.397 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.1 mm -53.39 -41.7 45.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.189 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.4 -31.51 61.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.029 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -108.64 30.82 6.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.994 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.913 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 9.4 mtt180 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.982 0.42 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.4 t -136.88 133.58 48.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.003 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.74 -69.74 0.29 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.074 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 14.2 mmt85 56.55 65.08 1.5 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.92 0.391 . . . . 0.0 110.804 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.5 t -83.92 -66.58 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.331 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.433 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 3.8 m0 -97.48 134.41 22.59 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.895 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 6' ' ' TRP . 68.2 Cg_endo -90.2 -57.22 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.792 2.328 . . . . 0.0 113.721 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -89.12 -31.87 17.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.822 0.344 . . . . 0.0 111.308 -179.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.433 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 17.6 t -52.86 -65.59 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.282 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.5 mt -59.49 -38.31 74.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.15 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -55.85 -19.85 13.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.505 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -81.16 -51.92 7.91 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.8 t -59.26 -34.47 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.02 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.0 mt -67.78 -51.77 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.002 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.47 -22.61 67.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.437 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.49 -9.82 64.35 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.122 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -116.29 -37.98 3.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.869 0.335 . . . . 0.0 111.192 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -74.6 -27.2 60.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.144 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.7 mt -57.9 -20.81 39.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.304 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.416 ' CZ ' ' HE3' ' A' ' 24' ' ' LYS . 1.5 t80 -115.99 -65.69 1.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.372 . . . . 0.0 110.913 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.73 -45.1 74.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.553 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.81 -53.21 10.77 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.274 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.1 mm -55.37 -50.61 64.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.007 0.432 . . . . 0.0 111.128 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.416 ' HE3' ' CZ ' ' A' ' 20' ' ' TYR . 24.6 mmtt -58.21 -30.48 66.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.069 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -60.0 -65.55 0.66 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.1 mtmm . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.89 -179.973 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.832 0.349 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.4 t 63.67 97.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.23 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.61 -65.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.919 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.4 -168.39 0.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.963 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.0 t -90.47 -55.97 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.068 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.475 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 1.6 m0 -80.64 114.88 51.42 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.628 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 6' ' ' TRP . 7.3 Cg_exo -73.58 -42.03 0.98 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.693 2.262 . . . . 0.0 113.748 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.64 -34.91 9.3 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.475 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 20.2 t -54.04 -55.21 15.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.974 0.416 . . . . 0.0 111.447 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.9 mt -68.91 -44.81 81.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.27 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.52 -22.47 8.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.859 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.8 p -82.38 -49.58 9.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -64.38 -35.13 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.113 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.3 mm -78.01 -37.5 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.101 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.5 -23.04 65.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.509 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.85 -7.52 29.19 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.602 -0.809 . . . . 0.0 113.313 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -115.85 -22.09 9.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.904 0.352 . . . . 0.0 111.574 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -117.74 -28.87 5.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.577 0.227 . . . . 0.0 111.367 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mt -97.84 25.85 5.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.879 0.371 . . . . 0.0 110.675 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -163.34 -59.88 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.224 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -43.3 74.93 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.995 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.94 -49.27 25.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.246 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.3 mt -51.51 -59.97 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.009 0.433 . . . . 0.0 111.131 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -53.46 -25.31 15.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.171 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -93.19 44.6 1.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.937 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.013 179.969 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.804 0.335 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.8 m -99.17 125.82 52.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.076 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -152.8 -46.46 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 68.4 mtm180 -140.54 109.94 6.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.026 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -110.81 -65.22 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.011 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.45 ' CE3' ' CG1' ' A' ' 9' ' ' VAL . 0.8 OUTLIER -93.49 147.29 33.41 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.695 179.812 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -89.12 -58.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.783 2.322 . . . . 0.0 113.944 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.58 -34.02 13.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.768 0.318 . . . . 0.0 111.293 -179.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.45 ' CG1' ' CE3' ' A' ' 6' ' ' TRP . 39.8 t -49.79 -57.4 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.558 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 78.2 mt -65.74 -44.46 93.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.147 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.88 -21.58 3.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.649 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.47 -50.27 9.62 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.0 t -61.91 -35.24 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.947 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 51.6 mt -61.25 -43.12 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.739 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.38 -24.52 65.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.102 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -112.27 15.36 25.3 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.875 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -118.89 -41.78 2.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.891 0.377 . . . . 0.0 110.963 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -73.55 -9.24 58.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.356 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.6 mt -85.06 -17.98 35.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.797 0.332 . . . . 0.0 111.325 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -123.84 -59.18 1.53 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.835 0.35 . . . . 0.0 110.81 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.67 -45.15 73.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.39 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.72 -52.03 11.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.068 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.6 mm -51.82 -41.63 30.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.172 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -55.18 -34.56 63.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.091 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -66.29 -33.08 74.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.916 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.295 -0.859 . . . . 0.0 110.871 179.959 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.819 0.342 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.7 m -76.53 149.71 6.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.15 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -113.7 -57.49 2.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.875 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -82.62 116.2 21.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.811 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.7 t -127.52 -65.87 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.993 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.458 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 1.9 m0 -104.36 141.18 22.0 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.59 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -89.54 -58.57 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.684 2.256 . . . . 0.0 113.684 -179.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 pp -93.09 -30.94 15.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.791 0.329 . . . . 0.0 111.372 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.458 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 21.3 t -50.08 -57.98 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.427 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.418 ' CG2' ' CD1' ' A' ' 14' ' ' ILE . 23.0 mt -66.55 -40.14 85.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.244 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.3 tpt85 -56.33 -20.09 17.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.653 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.4 p -82.94 -49.71 9.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.347 0.594 . . . . 0.0 109.451 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.2 t -60.81 -34.64 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.138 178.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.418 ' CD1' ' CG2' ' A' ' 10' ' ' ILE . 43.5 mt -73.02 -38.15 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.265 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.15 5.35 30.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.592 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.12 -22.78 1.09 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.456 -0.878 . . . . 0.0 113.238 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -119.23 -30.09 5.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 117.035 0.417 . . . . 0.0 111.601 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.408 ' HB2' ' HA ' ' A' ' 14' ' ' ILE . 1.4 m-20 -84.34 5.56 26.48 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 mt -79.96 -9.71 59.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.712 0.291 . . . . 0.0 111.029 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.98 -60.24 0.97 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.886 0.374 . . . . 0.0 110.634 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -43.4 83.2 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.238 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.406 ' HB3' ' CA ' ' A' ' 18' ' ' ASN . . . -76.27 -50.9 13.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.217 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.0 mm -47.5 -62.9 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.34 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -53.63 -30.31 42.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.013 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.68 -62.22 1.57 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.945 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.727 ' O ' HD12 ' A' ' 10' ' ' ILE . 1.0 OUTLIER . . . . . 0 CA--C 1.53 0.209 0 CA-C-O 120.494 0.188 . . . . 0.0 110.544 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 6' ' ' TRP . 3.0 Cg_exo -75.61 -41.92 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.772 2.315 . . . . 0.0 113.591 -178.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.8 ' O ' HG23 ' A' ' 12' ' ' THR . 3.3 pp -98.93 -37.09 9.54 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.466 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 19.7 t -52.25 -59.5 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.905 0.384 . . . . 0.0 111.473 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.727 HD12 ' O ' ' A' ' 6' ' ' TRP . 24.8 mt -58.87 -43.69 88.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.266 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.5 ttt180 -55.13 -20.59 10.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.809 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.8 HG23 ' O ' ' A' ' 8' ' ' LEU . 4.7 p -82.59 -50.08 9.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.213 0.53 . . . . 0.0 109.596 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.8 t -65.71 -35.03 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.35 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.553 HG23 ' HB3' ' A' ' 18' ' ' ASN . 34.4 mm . . . . . 0 N--CA 1.45 -0.47 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.175 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.553 ' HB3' HG23 ' A' ' 14' ' ' ILE . 5.6 t30 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.578 0.228 . . . . 0.0 111.505 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mt -94.85 -30.08 14.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.948 0.404 . . . . 0.0 110.586 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -124.31 -49.91 1.79 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.692 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -59.5 -43.65 93.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.059 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.409 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . . . -73.19 -53.72 10.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.242 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.4 mm -50.7 -55.74 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.178 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.6 mttp -55.73 -25.05 38.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.224 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-O 120.891 0.377 . . . . 0.0 110.927 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.515 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 2.3 m0 . . . . . 0 CA--C 1.53 0.18 0 CA-C-O 120.52 0.2 . . . . 0.0 110.608 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 6' ' ' TRP . 7.5 Cg_exo -73.71 -40.51 1.43 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.739 2.293 . . . . 0.0 113.614 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.17 -36.55 8.9 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.515 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 20.6 t -55.68 -56.96 9.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.851 0.358 . . . . 0.0 111.272 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.441 HG12 ' HB2' ' A' ' 6' ' ' TRP . 36.8 mm -54.56 -43.67 65.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.915 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.64 -20.33 13.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.492 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.6 m -80.55 -53.14 6.84 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.5 t -62.01 -35.2 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.169 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.3 mm . . . . . 0 N--CA 1.449 -0.5 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.095 179.888 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.436 ' HA ' ' CB ' ' A' ' 22' ' ' ALA . 46.5 t30 . . . . . 0 CA--C 1.528 0.119 0 CA-C-O 120.596 0.236 . . . . 0.0 111.563 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 87.7 mt -104.71 24.02 12.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.002 0.43 . . . . 0.0 110.811 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -170.0 -59.96 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.304 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -64.56 -39.67 94.18 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.793 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.436 ' CB ' ' HA ' ' A' ' 18' ' ' ASN . . . -76.66 -44.2 34.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.6 mt -51.46 -54.73 10.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.115 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.2 pttm -55.08 -31.41 61.16 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.101 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.964 -179.912 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.823 ' O ' HD12 ' A' ' 10' ' ' ILE . 2.9 m0 . . . . . 0 CA--C 1.53 0.191 0 CA-C-O 120.508 0.194 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -73.64 -39.82 1.76 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.894 2.396 . . . . 0.0 113.599 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.77 -38.68 9.38 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.481 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 21.0 t -53.89 -61.98 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.872 0.367 . . . . 0.0 111.259 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.823 HD12 ' O ' ' A' ' 6' ' ' TRP . 19.1 mt -55.51 -40.01 56.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.986 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.635 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -57.88 -18.83 25.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.274 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.6 m -81.79 -51.51 8.07 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 39.5 t -59.94 -34.86 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.044 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.823 HD11 HG22 ' A' ' 10' ' ' ILE . 45.2 mt . . . . . 0 N--CA 1.452 -0.33 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.882 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.522 ' ND2' HG22 ' A' ' 14' ' ' ILE . 55.9 p30 . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.985 HD22 HD11 ' A' ' 23' ' ' ILE . 7.5 mt -104.6 -55.88 2.27 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.848 0.356 . . . . 0.0 110.534 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -56.53 -60.39 3.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.537 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.9 ttm180 -58.76 -52.11 67.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.059 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -58.47 -59.15 5.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.182 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.985 HD11 HD22 ' A' ' 19' ' ' LEU . 66.9 mt -51.44 -45.42 34.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.897 0.379 . . . . 0.0 110.954 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.24 -33.84 65.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.933 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.5 tttm . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 179.996 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.639 ' O ' HD12 ' A' ' 10' ' ' ILE . 2.1 m0 . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.561 0.22 . . . . 0.0 110.7 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -72.41 -39.6 2.72 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.724 2.283 . . . . 0.0 113.807 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.74 -37.14 8.85 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.472 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 22.9 t -55.47 -58.23 5.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.867 0.365 . . . . 0.0 111.268 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.948 HG22 HD11 ' A' ' 14' ' ' ILE . 15.6 mt -64.01 -40.82 90.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.204 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -57.25 -21.06 31.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.613 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.15 -48.22 10.07 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.9 t -61.03 -34.1 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.997 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.948 HD11 HG22 ' A' ' 10' ' ' ILE . 43.2 mt . . . . . 0 N--CA 1.451 -0.391 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.135 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.507 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 33.5 m-20 . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 120.613 0.244 . . . . 0.0 111.419 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.64 -21.22 30.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.811 0.339 . . . . 0.0 110.799 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -127.51 -54.91 1.34 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.651 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.68 -42.23 78.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.334 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -77.98 -50.54 11.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.289 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.5 mm -50.17 -52.54 14.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.421 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.1 pttm -53.39 -33.03 52.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.063 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.7 tptm . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.815 -179.874 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.448 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 5.3 m0 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.599 0.238 . . . . 0.0 110.69 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.841 ' HG2' HD23 ' A' ' 8' ' ' LEU . 68.6 Cg_endo -87.04 -58.53 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.659 2.239 . . . . 0.0 113.751 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.907 ' O ' HG23 ' A' ' 12' ' ' THR . 0.5 OUTLIER -95.78 -33.49 12.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.71 0.29 . . . . 0.0 111.428 -179.147 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.448 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 22.0 t -49.31 -53.07 9.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.895 0.378 . . . . 0.0 111.536 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.426 HG22 ' CG1' ' A' ' 14' ' ' ILE . 29.7 mm -71.44 -46.41 64.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.082 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.6 tpt85 -51.71 -22.91 3.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.663 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.907 HG23 ' O ' ' A' ' 8' ' ' LEU . 43.2 p -81.31 -50.52 9.41 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.1 t -63.41 -35.23 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.123 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.426 ' CG1' HG22 ' A' ' 10' ' ' ILE . 32.1 mm . . . . . 0 N--CA 1.453 -0.319 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.017 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.44 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 8.3 m-20 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.6 0.238 . . . . 0.0 111.274 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.701 HD12 ' N ' ' A' ' 20' ' ' TYR . 0.3 OUTLIER -87.13 -17.49 32.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.869 179.715 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.701 ' N ' HD12 ' A' ' 19' ' ' LEU . 10.7 t80 -131.84 -51.05 0.97 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.584 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -58.24 -43.5 87.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.857 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -77.93 -50.85 11.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.186 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.4 mm -50.48 -47.34 27.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.268 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.0 mmtm -53.89 -32.76 54.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.077 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.906 -179.924 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.527 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 3.5 m0 . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 120.761 0.315 . . . . 0.0 110.53 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -64.9 -35.81 42.39 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.988 2.459 . . . . 0.0 113.798 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.84 -38.73 8.93 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.527 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 42.0 t -55.72 -59.55 2.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.927 0.394 . . . . 0.0 111.26 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.895 HG22 HD11 ' A' ' 14' ' ' ILE . 42.4 mm -54.42 -38.62 41.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.191 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.457 ' HA ' HD12 ' A' ' 14' ' ' ILE . 16.1 ttp-105 -55.97 -19.28 11.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.576 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.6 p -82.18 -51.34 8.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.334 0.587 . . . . 0.0 109.547 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.4 t -61.51 -34.99 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.286 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.895 HD11 HG22 ' A' ' 10' ' ' ILE . 46.8 mt . . . . . 0 N--CA 1.451 -0.383 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.016 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.466 ' HB2' HG23 ' A' ' 14' ' ' ILE . 3.4 m-20 . . . . . 0 CA--C 1.529 0.158 0 N-CA-C 111.598 0.221 . . . . 0.0 111.598 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.739 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.9 OUTLIER -88.49 -19.56 26.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.854 0.359 . . . . 0.0 110.785 179.618 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.511 ' CD2' HD12 ' A' ' 19' ' ' LEU . 10.7 m-85 -129.48 -50.2 1.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.494 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.58 -45.34 94.53 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.28 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -72.75 -53.43 11.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.231 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.739 HD12 ' O ' ' A' ' 19' ' ' LEU . 28.8 mt -53.83 -38.66 36.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.997 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.3 mmtm -57.19 -35.76 69.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.954 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.936 179.955 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.531 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 0.6 OUTLIER . . . . . 0 CA--C 1.53 0.18 0 CA-C-O 120.617 0.246 . . . . 0.0 110.595 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.53 -37.97 15.66 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.871 2.381 . . . . 0.0 113.938 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.42 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.6 OUTLIER -102.99 -35.72 8.46 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.519 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.531 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 38.4 t -56.59 -51.39 66.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.86 0.362 . . . . 0.0 111.267 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.447 HG22 ' CG1' ' A' ' 14' ' ' ILE . 50.7 mm -57.97 -49.18 82.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.157 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.3 ttt-85 -52.92 -22.32 5.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.459 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.2 m -82.12 -49.89 9.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.316 0.579 . . . . 0.0 109.497 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.9 t -64.63 -35.43 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.234 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.447 ' CG1' HG22 ' A' ' 10' ' ' ILE . 27.4 mm . . . . . 0 N--CA 1.452 -0.326 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.842 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.615 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 2.5 m-80 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.721 0.296 . . . . 0.0 111.393 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.653 ' O ' HD12 ' A' ' 23' ' ' ILE . 3.3 pp -90.32 -22.94 21.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.838 0.351 . . . . 0.0 110.679 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -121.81 -54.39 1.94 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.518 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -48.39 81.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.268 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -65.99 -56.06 13.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.357 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.653 HD12 ' O ' ' A' ' 19' ' ' LEU . 16.6 mt -53.13 -48.29 53.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.907 0.384 . . . . 0.0 111.174 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -33.25 67.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.026 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.903 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.455 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.575 0.226 . . . . 0.0 110.587 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.434 ' HG2' HD23 ' A' ' 8' ' ' LEU . 70.4 Cg_endo -89.16 -58.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.598 2.199 . . . . 0.0 113.775 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.434 HD23 ' HG2' ' A' ' 7' ' ' PRO . 0.7 OUTLIER -93.15 -30.63 15.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.74 0.305 . . . . 0.0 111.392 -178.996 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.455 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 16.9 t -52.9 -59.15 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.265 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.425 HG12 ' HB2' ' A' ' 6' ' ' TRP . 28.7 mm -58.65 -48.55 85.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.994 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.23 -18.66 4.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.558 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.1 m -82.72 -49.36 9.85 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.1 t -62.96 -36.24 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.052 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 72.2 mt . . . . . 0 N--CA 1.451 -0.376 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.474 179.465 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.423 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.9 t-20 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.646 0.26 . . . . 0.0 111.423 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 mt -92.54 18.58 8.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 110.994 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -157.07 -55.34 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.11 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.17 -45.6 66.38 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.754 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -75.26 -38.11 60.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.09 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.2 mm -52.37 -56.31 7.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.323 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.9 mmtm -51.92 -33.61 38.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.081 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.2 mttt . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 -179.905 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.513 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 1.1 m0 . . . . . 0 CA--C 1.53 0.186 0 CA-C-O 120.75 0.31 . . . . 0.0 110.706 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.85 -36.61 13.16 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.019 2.479 . . . . 0.0 113.582 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.77 -41.55 9.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.721 0.296 . . . . 0.0 111.485 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.513 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 39.7 t -52.7 -66.11 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.093 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.625 HG22 HD11 ' A' ' 14' ' ' ILE . 36.1 mm -55.98 -30.49 28.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.013 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.517 ' HA ' HD12 ' A' ' 14' ' ' ILE . 4.3 ttm-85 -54.39 -20.8 8.07 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.641 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.431 ' CG2' ' N ' ' A' ' 13' ' ' VAL . 1.3 t -82.51 -47.15 12.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.175 0.512 . . . . 0.0 109.714 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.431 ' N ' ' CG2' ' A' ' 12' ' ' THR . 26.4 t -62.64 -34.33 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.783 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.625 HD11 HG22 ' A' ' 10' ' ' ILE . 27.7 mt . . . . . 0 N--CA 1.449 -0.483 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.098 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.601 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 6.8 m-20 . . . . . 0 CA--C 1.53 0.179 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.8 pp -77.91 -21.24 51.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.853 0.358 . . . . 0.0 110.871 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -128.46 -51.89 1.27 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.956 0.407 . . . . 0.0 110.593 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.39 -42.72 87.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.065 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -78.64 -51.03 10.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.217 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.5 mm -49.91 -55.16 5.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.33 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -53.54 -30.21 40.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.158 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.3 ttpp . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 -179.905 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.652 ' O ' HD12 ' A' ' 10' ' ' ILE . 3.6 m0 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.648 0.261 . . . . 0.0 110.607 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.787 ' HG2' HD23 ' A' ' 8' ' ' LEU . 66.4 Cg_endo -86.33 -57.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.684 2.256 . . . . 0.0 113.85 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.787 HD23 ' HG2' ' A' ' 7' ' ' PRO . 0.3 OUTLIER -89.56 -30.7 18.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.814 0.34 . . . . 0.0 111.278 -178.975 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 6' ' ' TRP . 12.8 t -55.39 -65.84 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.652 HD12 ' O ' ' A' ' 6' ' ' TRP . 15.0 mt -59.21 -37.8 70.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.985 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.93 -22.28 3.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.588 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.611 HG23 ' O ' ' A' ' 8' ' ' LEU . 18.2 p -78.46 -54.27 6.35 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.9 t -61.24 -34.99 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.11 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.613 ' CG1' HG22 ' A' ' 10' ' ' ILE . 29.8 mm . . . . . 0 N--CA 1.451 -0.384 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.925 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.575 ' HA ' ' HB2' ' A' ' 22' ' ' ALA . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.111 0 CA-C-O 120.667 0.27 . . . . 0.0 111.407 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.466 ' HA ' HD23 ' A' ' 19' ' ' LEU . 13.4 mt -101.28 -32.87 10.29 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.937 0.398 . . . . 0.0 110.427 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -120.53 -49.14 2.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.252 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -48.63 80.94 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.874 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.575 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . . . -59.94 -45.9 91.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.062 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.9 mm -51.4 -41.58 26.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.221 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.4 mtpt -54.16 -34.21 59.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.067 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.849 179.973 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.48 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.793 0.33 . . . . 0.0 110.741 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -63.48 -35.57 59.68 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 123.053 2.502 . . . . 0.0 113.442 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 pp -94.19 -42.2 9.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.901 0.381 . . . . 0.0 111.386 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.48 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 19.5 t -54.3 -59.65 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.091 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.417 HG22 ' CD1' ' A' ' 14' ' ' ILE . 62.9 mt -56.03 -40.73 65.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.972 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.46 -18.33 27.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.374 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.7 m -82.36 -51.55 7.76 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.7 t -58.65 -34.59 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.94 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.417 ' CD1' HG22 ' A' ' 10' ' ' ILE . 97.1 mt . . . . . 0 N--CA 1.451 -0.423 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.847 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.646 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 3.5 m120 . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.77 0.319 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.1 mt -58.09 -19.92 35.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.252 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -114.82 -62.29 1.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.921 0.391 . . . . 0.0 110.814 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -49.54 75.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.441 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -72.41 -52.5 15.67 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.391 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.5 mm -54.85 -53.17 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.972 0.415 . . . . 0.0 111.1 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.92 -29.13 62.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.04 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.3 mmtt . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.904 179.957 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.467 ' CE3' ' CG1' ' A' ' 9' ' ' VAL . 2.8 m0 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.587 0.232 . . . . 0.0 110.821 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -89.73 -57.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.812 2.341 . . . . 0.0 113.885 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.1 pp -92.48 -31.53 15.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.746 0.308 . . . . 0.0 111.469 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.467 ' CG1' ' CE3' ' A' ' 6' ' ' TRP . 18.5 t -53.22 -60.19 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.314 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.705 HG22 HD11 ' A' ' 14' ' ' ILE . 36.5 mm -63.89 -34.95 71.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.795 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.527 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.2 OUTLIER -54.57 -20.12 7.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.421 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -80.67 -52.0 8.05 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.2 t -59.03 -34.69 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.084 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.705 HD11 HG22 ' A' ' 10' ' ' ILE . 30.9 mt . . . . . 0 N--CA 1.452 -0.342 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.84 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 5.5 t30 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.684 0.278 . . . . 0.0 111.486 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.9 mt -85.38 -25.36 27.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.217 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.5 27.18 7.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.957 0.408 . . . . 0.0 111.077 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 16.1 ttp85 -146.69 -48.18 0.19 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.267 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -80.77 -34.4 34.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.113 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.5 mm -57.26 -57.55 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.002 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.72 -30.63 33.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.139 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.88 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.478 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.9 OUTLIER . . . . . 0 CA--C 1.531 0.225 0 CA-C-O 120.542 0.211 . . . . 0.0 110.609 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.78 ' HG2' HD23 ' A' ' 8' ' ' LEU . 65.1 Cg_endo -83.14 -57.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.578 2.185 . . . . 0.0 114.067 -178.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 12' ' ' THR . 0.7 OUTLIER -88.76 -31.22 18.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.761 0.315 . . . . 0.0 111.351 -178.897 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 6' ' ' TRP . 18.8 t -52.92 -65.77 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.319 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.1 mt -56.9 -41.03 75.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.236 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.65 -21.3 10.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.7 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.818 HG23 ' O ' ' A' ' 8' ' ' LEU . 6.1 p -83.54 -48.25 10.46 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.8 t -62.95 -35.0 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.155 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.8 mm . . . . . 0 N--CA 1.45 -0.46 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.087 179.942 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.568 ' HA ' ' HB2' ' A' ' 22' ' ' ALA . 48.3 t30 . . . . . 0 CA--C 1.528 0.13 0 CA-C-O 120.583 0.23 . . . . 0.0 111.47 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 19' ' ' LEU . 16.1 mt -101.63 -26.6 13.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.859 0.361 . . . . 0.0 110.63 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.87 -55.69 2.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.555 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -48.77 80.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.134 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.568 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . . . -60.08 -48.45 81.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.256 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.1 mm -51.47 -48.12 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.239 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.07 -33.3 51.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.182 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 179.984 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.818 ' O ' HD12 ' A' ' 10' ' ' ILE . 1.4 m0 . . . . . 0 CA--C 1.531 0.212 0 CA-C-O 120.498 0.19 . . . . 0.0 110.699 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.62 -40.27 1.57 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.815 2.343 . . . . 0.0 113.687 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.577 ' O ' HG23 ' A' ' 12' ' ' THR . 0.4 OUTLIER -98.12 -37.76 9.59 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -178.776 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.486 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 19.3 t -54.47 -61.46 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.873 0.368 . . . . 0.0 111.423 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.818 HD12 ' O ' ' A' ' 6' ' ' TRP . 16.1 mt -57.39 -38.57 63.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.129 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -19.53 10.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.518 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 8' ' ' LEU . 14.2 p -83.28 -49.86 8.97 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.9 t -60.94 -34.72 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.267 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.547 ' CD1' HG22 ' A' ' 10' ' ' ILE . 96.2 mt . . . . . 0 N--CA 1.451 -0.379 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.962 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.653 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 5.3 m120 . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 120.825 0.345 . . . . 0.0 110.855 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.9 mt -59.45 -19.66 49.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.065 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -125.71 -55.72 1.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.727 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.14 -33.88 69.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.419 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -91.36 -47.68 7.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.335 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.9 mm -55.86 -40.12 60.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.963 0.411 . . . . 0.0 111.104 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -56.14 -34.83 66.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.023 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.7 mtpp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.927 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.784 ' O ' HD12 ' A' ' 10' ' ' ILE . 1.8 m0 . . . . . 0 CA--C 1.529 0.155 0 CA-C-O 120.64 0.257 . . . . 0.0 110.664 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -70.88 -38.85 4.87 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.884 2.389 . . . . 0.0 113.775 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.444 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -98.57 -37.91 9.36 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -178.695 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.473 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 21.3 t -54.15 -61.39 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.999 0.428 . . . . 0.0 111.235 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.784 HD12 ' O ' ' A' ' 6' ' ' TRP . 18.8 mt -55.57 -41.33 63.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.002 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.9 ttt85 -59.28 -17.44 28.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.301 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.28 -50.04 8.79 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 39.4 t -59.9 -34.85 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.982 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 68.3 mt . . . . . 0 N--CA 1.449 -0.511 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.927 179.813 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.603 ' CG ' ' HB2' ' A' ' 22' ' ' ALA . 0.6 OUTLIER . . . . . 0 CA--C 1.53 0.199 0 CA-C-O 120.471 0.177 . . . . 0.0 111.342 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 mt -84.15 -30.69 25.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.95 0.405 . . . . 0.0 110.597 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -118.39 -52.02 2.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.587 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.42 -48.64 74.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.134 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.603 ' HB2' ' CG ' ' A' ' 18' ' ' ASN . . . -70.6 -53.91 14.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.936 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.0 mm -53.72 -44.79 60.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.095 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -56.73 -35.5 68.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.002 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.944 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.515 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 2.2 m0 . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 120.538 0.208 . . . . 0.0 110.668 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.749 ' HG2' HD23 ' A' ' 8' ' ' LEU . 66.6 Cg_endo -88.37 -57.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.679 2.253 . . . . 0.0 113.828 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.749 HD23 ' HG2' ' A' ' 7' ' ' PRO . 0.3 OUTLIER -91.02 -33.93 15.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.801 0.334 . . . . 0.0 111.28 -179.167 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.515 ' HB ' ' HB3' ' A' ' 6' ' ' TRP . 21.5 t -51.45 -62.57 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.377 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.665 HG22 HD11 ' A' ' 14' ' ' ILE . 30.5 mt -61.18 -34.54 60.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.839 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.85 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -52.1 -21.94 3.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.463 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.1 m -79.29 -52.52 8.01 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.8 t -60.35 -34.63 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.951 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.85 HD12 ' HA ' ' A' ' 11' ' ' ARG . 47.1 mt . . . . . 0 N--CA 1.453 -0.323 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.799 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.628 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 4.6 m-80 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.672 0.272 . . . . 0.0 111.268 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 19' ' ' LEU . 12.3 mt -53.29 -23.22 8.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.177 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -126.1 -56.86 1.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.338 . . . . 0.0 110.797 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.51 -32.87 67.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.379 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -90.25 -48.38 7.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.397 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.1 mm -53.39 -41.7 45.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.189 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.4 -31.51 61.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.029 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.994 -179.993 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.57 ' O ' HD12 ' A' ' 10' ' ' ILE . 3.8 m0 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.521 0.2 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.516 ' HG2' HD23 ' A' ' 8' ' ' LEU . 68.2 Cg_endo -90.2 -57.22 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.792 2.328 . . . . 0.0 113.721 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.516 HD23 ' HG2' ' A' ' 7' ' ' PRO . 0.7 OUTLIER -89.12 -31.87 17.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.822 0.344 . . . . 0.0 111.308 -179.125 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.45 ' HB ' ' HB3' ' A' ' 6' ' ' TRP . 17.6 t -52.86 -65.59 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.282 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.869 HG22 HD11 ' A' ' 14' ' ' ILE . 19.5 mt -59.49 -38.31 74.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.15 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.576 ' HA ' HD12 ' A' ' 14' ' ' ILE . 1.6 tpm_? -55.85 -19.85 13.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.505 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -81.16 -51.92 7.91 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.8 t -59.26 -34.47 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.02 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.869 HD11 HG22 ' A' ' 10' ' ' ILE . 40.0 mt . . . . . 0 N--CA 1.451 -0.386 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.002 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.765 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 2.4 m-80 . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.785 0.326 . . . . 0.0 111.144 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 19' ' ' LEU . 10.7 mt -57.9 -20.81 39.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.304 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.424 ' CZ ' ' HE3' ' A' ' 24' ' ' LYS . 1.5 t80 -115.99 -65.69 1.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.372 . . . . 0.0 110.913 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.73 -45.1 74.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.553 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.765 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -73.81 -53.21 10.77 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.274 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.1 mm -55.37 -50.61 64.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.007 0.432 . . . . 0.0 111.128 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.424 ' HE3' ' CZ ' ' A' ' 20' ' ' TYR . 24.6 mmtt -58.21 -30.48 66.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.069 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.3 mttp . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.917 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.72 ' O ' HD12 ' A' ' 10' ' ' ILE . 1.6 m0 . . . . . 0 CA--C 1.531 0.231 0 CA-C-O 120.507 0.194 . . . . 0.0 110.628 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 6' ' ' TRP . 7.3 Cg_exo -73.58 -42.03 0.98 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.693 2.262 . . . . 0.0 113.748 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.897 ' O ' HG23 ' A' ' 12' ' ' THR . 0.5 OUTLIER -101.64 -34.91 9.3 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.702 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.486 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 20.2 t -54.04 -55.21 15.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.974 0.416 . . . . 0.0 111.447 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.72 HD12 ' O ' ' A' ' 6' ' ' TRP . 10.9 mt -68.91 -44.81 81.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.27 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.52 -22.47 8.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.859 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.897 HG23 ' O ' ' A' ' 8' ' ' LEU . 50.8 p -82.38 -49.58 9.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -64.38 -35.13 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.113 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.526 ' CG1' HG22 ' A' ' 10' ' ' ILE . 36.3 mm . . . . . 0 N--CA 1.45 -0.444 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.101 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.577 0.227 . . . . 0.0 111.367 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.422 ' HA ' HD11 ' A' ' 23' ' ' ILE . 5.9 mt -97.84 25.85 5.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.879 0.371 . . . . 0.0 110.675 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -163.34 -59.88 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.224 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -43.3 74.93 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.995 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.94 -49.27 25.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.246 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.422 HD11 ' HA ' ' A' ' 19' ' ' LEU . 35.3 mt -51.51 -59.97 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.009 0.433 . . . . 0.0 111.131 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -53.46 -25.31 15.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.171 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.937 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.456 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.621 0.248 . . . . 0.0 110.695 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.823 ' HG2' HD23 ' A' ' 8' ' ' LEU . 70.8 Cg_endo -89.12 -58.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.783 2.322 . . . . 0.0 113.944 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.823 HD23 ' HG2' ' A' ' 7' ' ' PRO . 0.4 OUTLIER -93.58 -34.02 13.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.768 0.318 . . . . 0.0 111.293 -179.039 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.456 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 39.8 t -49.79 -57.4 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.558 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.854 HG22 HD11 ' A' ' 14' ' ' ILE . 78.2 mt -65.74 -44.46 93.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.147 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.747 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -51.88 -21.58 3.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.649 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.47 -50.27 9.62 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.0 t -61.91 -35.24 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.947 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.854 HD11 HG22 ' A' ' 10' ' ' ILE . 51.6 mt . . . . . 0 N--CA 1.454 -0.271 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.739 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.554 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 20.7 t-20 . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 120.59 0.233 . . . . 0.0 111.356 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.6 mt -85.06 -17.98 35.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.797 0.332 . . . . 0.0 111.325 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -123.84 -59.18 1.53 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.835 0.35 . . . . 0.0 110.81 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.67 -45.15 73.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.39 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -75.72 -52.03 11.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.068 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.6 mm -51.82 -41.63 30.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.172 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -55.18 -34.56 63.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.091 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.916 -179.982 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.471 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 1.9 m0 . . . . . 0 CA--C 1.528 0.105 0 CA-C-O 120.562 0.22 . . . . 0.0 110.59 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -89.54 -58.57 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.684 2.256 . . . . 0.0 113.684 -179.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.892 ' O ' HG23 ' A' ' 12' ' ' THR . 2.9 pp -93.09 -30.94 15.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.791 0.329 . . . . 0.0 111.372 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.471 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 21.3 t -50.08 -57.98 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.427 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.912 HG22 HD11 ' A' ' 14' ' ' ILE . 23.0 mt -66.55 -40.14 85.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.244 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.3 tpt85 -56.33 -20.09 17.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.653 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.892 HG23 ' O ' ' A' ' 8' ' ' LEU . 21.4 p -82.94 -49.71 9.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.347 0.594 . . . . 0.0 109.451 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.2 t -60.81 -34.64 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.138 178.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.912 HD11 HG22 ' A' ' 10' ' ' ILE . 43.5 mt . . . . . 0 N--CA 1.449 -0.487 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.265 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.675 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.4 m-20 . . . . . 0 CA--C 1.529 0.161 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 mt -79.96 -9.71 59.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.712 0.291 . . . . 0.0 111.029 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.98 -60.24 0.97 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.886 0.374 . . . . 0.0 110.634 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -43.4 83.2 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.238 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -76.27 -50.9 13.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.217 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.0 mm -47.5 -62.9 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.34 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -53.63 -30.31 42.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.013 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.788 0.327 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.1 m -71.16 157.44 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.145 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.1 -30.3 7.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.912 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -167.49 111.01 0.67 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.843 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.731 HG12 ' CD1' ' A' ' 6' ' ' TRP . 2.7 t -106.59 -68.61 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.078 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.731 ' CD1' HG12 ' A' ' 5' ' ' VAL . 1.0 OUTLIER -111.29 111.18 55.6 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.544 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 6' ' ' TRP . 3.0 Cg_exo -75.61 -41.92 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.772 2.315 . . . . 0.0 113.591 -178.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.8 ' O ' HG23 ' A' ' 12' ' ' THR . 3.3 pp -98.93 -37.09 9.54 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.466 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 19.7 t -52.25 -59.5 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.905 0.384 . . . . 0.0 111.473 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.727 HD12 ' O ' ' A' ' 6' ' ' TRP . 24.8 mt -58.87 -43.69 88.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.266 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.444 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 8.5 ttt180 -55.13 -20.59 10.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.809 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.8 HG23 ' O ' ' A' ' 8' ' ' LEU . 4.7 p -82.59 -50.08 9.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.213 0.53 . . . . 0.0 109.596 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.8 t -65.71 -35.03 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.35 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.553 HG23 ' HB3' ' A' ' 18' ' ' ASN . 34.4 mm -77.02 -41.68 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.175 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.457 ' HA ' HD12 ' A' ' 19' ' ' LEU . . . -82.34 0.7 40.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.618 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.1 -19.25 4.38 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.922 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -147.63 13.79 1.06 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.838 0.319 . . . . 0.0 111.769 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.553 ' HB3' HG23 ' A' ' 14' ' ' ILE . 5.6 t30 -136.11 4.9 3.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.578 0.228 . . . . 0.0 111.505 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 15' ' ' ALA . 5.4 mt -94.85 -30.08 14.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.948 0.404 . . . . 0.0 110.586 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -124.31 -49.91 1.79 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.692 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -59.5 -43.65 93.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.059 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.409 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . . . -73.19 -53.72 10.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.242 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.4 mm -50.7 -55.74 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.178 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.6 mttp -55.73 -25.05 38.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.224 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.06 41.1 1.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.891 0.377 . . . . 0.0 110.927 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.881 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.748 0.309 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 3' ' ' LYS . 20.2 t -116.68 159.37 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.043 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.47 ' N ' HG12 ' A' ' 2' ' ' VAL . 17.0 mtpt -58.67 151.94 19.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.49 115.14 27.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.945 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.5 -59.71 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.039 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.515 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 2.3 m0 -77.12 121.87 85.36 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.608 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 6' ' ' TRP . 7.5 Cg_exo -73.71 -40.51 1.43 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.739 2.293 . . . . 0.0 113.614 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.17 -36.55 8.9 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.515 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 20.6 t -55.68 -56.96 9.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.851 0.358 . . . . 0.0 111.272 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.441 HG12 ' HB2' ' A' ' 6' ' ' TRP . 36.8 mm -54.56 -43.67 65.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.915 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.64 -20.33 13.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.492 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.6 m -80.55 -53.14 6.84 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.5 t -62.01 -35.2 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.169 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.3 mm -74.98 -38.22 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.095 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.07 -17.47 62.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.389 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.07 13.41 19.49 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.756 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -114.28 -69.6 0.85 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.973 0.416 . . . . 0.0 110.989 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.436 ' HA ' ' CB ' ' A' ' 22' ' ' ALA . 46.5 t30 -72.47 -9.95 59.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.563 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 87.7 mt -104.71 24.02 12.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.002 0.43 . . . . 0.0 110.811 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -170.0 -59.96 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.304 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -64.56 -39.67 94.18 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.793 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.436 ' CB ' ' HA ' ' A' ' 18' ' ' ASN . . . -76.66 -44.2 34.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.6 mt -51.46 -54.73 10.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.115 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.2 pttm -55.08 -31.41 61.16 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.101 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -71.7 -33.42 68.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.964 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.0 pttt . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.921 179.924 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.744 0.307 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.504 ' O ' HG23 ' A' ' 2' ' ' VAL . 12.4 m -98.27 84.91 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.009 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.6 ptmm? -116.33 148.18 40.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.968 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -169.07 143.16 2.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.809 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.416 HG12 ' HD1' ' A' ' 6' ' ' TRP . 21.4 t -129.9 -62.99 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.251 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.823 ' O ' HD12 ' A' ' 10' ' ' ILE . 2.9 m0 -90.87 110.33 41.04 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.798 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -73.64 -39.82 1.76 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.894 2.396 . . . . 0.0 113.599 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.77 -38.68 9.38 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.481 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 21.0 t -53.89 -61.98 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.872 0.367 . . . . 0.0 111.259 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.823 HD12 ' O ' ' A' ' 6' ' ' TRP . 19.1 mt -55.51 -40.01 56.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.986 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.635 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -57.88 -18.83 25.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.274 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.6 m -81.79 -51.51 8.07 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 39.5 t -59.94 -34.86 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.044 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.823 HD11 HG22 ' A' ' 10' ' ' ILE . 45.2 mt -64.35 -44.7 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.882 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.494 ' O ' HD12 ' A' ' 19' ' ' LEU . . . -58.27 -31.92 67.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.924 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.35 -4.53 64.25 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.775 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -106.03 -37.53 6.6 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.887 0.375 . . . . 0.0 110.726 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.522 ' ND2' HG22 ' A' ' 14' ' ' ILE . 55.9 p30 -83.59 7.6 16.78 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.539 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.985 HD22 HD11 ' A' ' 23' ' ' ILE . 7.5 mt -104.6 -55.88 2.27 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.848 0.356 . . . . 0.0 110.534 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -56.53 -60.39 3.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.537 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.9 ttm180 -58.76 -52.11 67.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.059 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -58.47 -59.15 5.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.182 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.985 HD11 HD22 ' A' ' 19' ' ' LEU . 66.9 mt -51.44 -45.42 34.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.897 0.379 . . . . 0.0 110.954 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.24 -33.84 65.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.933 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.5 tttm -68.75 98.96 0.96 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.148 -0.929 . . . . 0.0 110.926 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.83 0.348 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.46 -51.11 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.106 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.4 tttp 59.78 78.56 0.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.782 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -102.07 160.05 14.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.954 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.473 HG12 ' H ' ' A' ' 6' ' ' TRP . 0.2 OUTLIER -94.36 -170.78 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.679 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.639 ' O ' HD12 ' A' ' 10' ' ' ILE . 2.1 m0 -70.55 110.16 6.43 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.7 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -72.41 -39.6 2.72 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.724 2.283 . . . . 0.0 113.807 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.74 -37.14 8.85 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.472 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 22.9 t -55.47 -58.23 5.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.867 0.365 . . . . 0.0 111.268 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.948 HG22 HD11 ' A' ' 14' ' ' ILE . 15.6 mt -64.01 -40.82 90.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.204 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -57.25 -21.06 31.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.613 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.15 -48.22 10.07 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.9 t -61.03 -34.1 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.997 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.948 HD11 HG22 ' A' ' 10' ' ' ILE . 43.2 mt -70.97 -39.72 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.135 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.26 3.96 40.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.664 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -133.76 -10.85 1.75 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.594 -0.813 . . . . 0.0 113.297 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -128.09 -31.63 2.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.012 0.406 . . . . 0.0 111.463 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.507 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 33.5 m-20 -90.39 19.8 4.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.419 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.64 -21.22 30.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.811 0.339 . . . . 0.0 110.799 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -127.51 -54.91 1.34 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.651 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.68 -42.23 78.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.334 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -77.98 -50.54 11.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.289 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.5 mm -50.17 -52.54 14.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.421 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.1 pttm -53.39 -33.03 52.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.063 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -88.58 98.37 11.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.815 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.8 mttt . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.887 -179.966 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 4.1 mtp85 . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.938 0.399 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.613 HG22 ' H ' ' A' ' 4' ' ' ARG . 10.9 p -176.41 138.51 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.067 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -125.67 30.57 5.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.941 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.613 ' H ' HG22 ' A' ' 2' ' ' VAL . 27.3 mtp180 63.03 143.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.117 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.414 HG12 ' H ' ' A' ' 6' ' ' TRP . 0.2 OUTLIER -103.22 -163.5 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.544 179.767 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.448 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 5.3 m0 -55.37 146.09 44.33 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-O 120.599 0.238 . . . . 0.0 110.69 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.841 ' HG2' HD23 ' A' ' 8' ' ' LEU . 68.6 Cg_endo -87.04 -58.53 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.659 2.239 . . . . 0.0 113.751 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.907 ' O ' HG23 ' A' ' 12' ' ' THR . 0.5 OUTLIER -95.78 -33.49 12.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.71 0.29 . . . . 0.0 111.428 -179.147 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.448 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 22.0 t -49.31 -53.07 9.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.895 0.378 . . . . 0.0 111.536 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.426 HG22 ' CG1' ' A' ' 14' ' ' ILE . 29.7 mm -71.44 -46.41 64.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.082 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.6 tpt85 -51.71 -22.91 3.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.663 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.907 HG23 ' O ' ' A' ' 8' ' ' LEU . 43.2 p -81.31 -50.52 9.41 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.1 t -63.41 -35.23 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.123 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.426 ' CG1' HG22 ' A' ' 10' ' ' ILE . 32.1 mm -68.33 -43.89 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.017 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.51 -11.77 61.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.663 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.51 -13.62 16.43 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.04 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.6 -35.9 3.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.875 0.338 . . . . 0.0 111.275 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.44 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 8.3 m-20 -94.74 21.23 7.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.274 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.701 HD12 ' N ' ' A' ' 20' ' ' TYR . 0.3 OUTLIER -87.13 -17.49 32.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.869 179.715 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.701 ' N ' HD12 ' A' ' 19' ' ' LEU . 10.7 t80 -131.84 -51.05 0.97 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.584 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -58.24 -43.5 87.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.857 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -77.93 -50.85 11.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.186 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.4 mm -50.48 -47.34 27.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.268 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.0 mmtm -53.89 -32.76 54.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.077 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -107.78 51.02 0.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.906 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.148 -0.929 . . . . 0.0 110.84 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.803 0.335 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.9 m -131.62 144.86 36.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.072 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -161.08 133.88 6.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.963 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 -106.51 -70.99 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.678 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.857 HG12 ' CD1' ' A' ' 6' ' ' TRP . 3.3 t -149.45 -73.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.857 ' CD1' HG12 ' A' ' 5' ' ' VAL . 3.5 m0 -111.04 99.31 42.54 Favored Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.53 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -64.9 -35.81 42.39 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.988 2.459 . . . . 0.0 113.798 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.84 -38.73 8.93 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.527 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 42.0 t -55.72 -59.55 2.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.927 0.394 . . . . 0.0 111.26 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.895 HG22 HD11 ' A' ' 14' ' ' ILE . 42.4 mm -54.42 -38.62 41.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.191 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.457 ' HA ' HD12 ' A' ' 14' ' ' ILE . 16.1 ttp-105 -55.97 -19.28 11.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.576 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.6 p -82.18 -51.34 8.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.334 0.587 . . . . 0.0 109.547 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.4 t -61.51 -34.99 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.286 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.895 HD11 HG22 ' A' ' 10' ' ' ILE . 46.8 mt -66.29 -38.46 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.016 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.26 -3.83 44.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.574 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -139.96 19.95 2.89 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.941 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -155.41 -33.98 0.09 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.576 0.227 . . . . 0.0 111.481 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.466 ' HB2' HG23 ' A' ' 14' ' ' ILE . 3.4 m-20 -87.08 16.42 5.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.598 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.739 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.9 OUTLIER -88.49 -19.56 26.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.854 0.359 . . . . 0.0 110.785 179.618 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.511 ' CD2' HD12 ' A' ' 19' ' ' LEU . 10.7 m-85 -129.48 -50.2 1.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.494 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.58 -45.34 94.53 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.28 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -72.75 -53.43 11.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.231 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.739 HD12 ' O ' ' A' ' 19' ' ' LEU . 28.8 mt -53.83 -38.66 36.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.997 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.3 mmtm -57.19 -35.76 69.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.954 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -69.74 92.11 0.66 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.936 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.2 mttp . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.955 -179.999 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.78 0.324 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.496 HG13 ' N ' ' A' ' 3' ' ' LYS . 12.2 p -136.49 -45.15 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.157 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.496 ' N ' HG13 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -74.12 -178.16 3.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.908 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -88.17 85.74 6.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.825 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.8 t -141.15 156.49 21.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.959 0.409 . . . . 0.0 111.137 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.531 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 0.6 OUTLIER -112.48 107.36 55.25 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.595 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.53 -37.97 15.66 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.871 2.381 . . . . 0.0 113.938 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.42 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.6 OUTLIER -102.99 -35.72 8.46 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.519 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.531 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 38.4 t -56.59 -51.39 66.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.86 0.362 . . . . 0.0 111.267 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.447 HG22 ' CG1' ' A' ' 14' ' ' ILE . 50.7 mm -57.97 -49.18 82.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.157 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.3 ttt-85 -52.92 -22.32 5.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.459 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.2 m -82.12 -49.89 9.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.316 0.579 . . . . 0.0 109.497 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.9 t -64.63 -35.43 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.234 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.447 ' CG1' HG22 ' A' ' 10' ' ' ILE . 27.4 mm -64.92 -39.43 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.842 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.04 -21.98 66.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.238 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.802 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -107.57 8.48 37.41 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.895 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -121.45 -37.94 2.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.832 0.349 . . . . 0.0 111.212 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.615 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 2.5 m-80 -95.15 20.1 9.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.393 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.802 HD23 ' HA2' ' A' ' 16' ' ' GLY . 3.3 pp -90.32 -22.94 21.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.838 0.351 . . . . 0.0 110.679 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -121.81 -54.39 1.94 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.518 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -48.39 81.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.268 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -65.99 -56.06 13.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.357 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.653 HD12 ' O ' ' A' ' 19' ' ' LEU . 16.6 mt -53.13 -48.29 53.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.907 0.384 . . . . 0.0 111.174 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -33.25 67.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.026 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.24 -36.12 79.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.903 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.2 mmmt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.898 -179.98 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 120.85 0.357 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.495 HG22 ' N ' ' A' ' 3' ' ' LYS . 11.9 p -91.76 158.97 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.08 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.495 ' N ' HG22 ' A' ' 2' ' ' VAL . 0.2 OUTLIER 66.66 92.59 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 62.17 116.77 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.986 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.676 HG12 ' CD1' ' A' ' 6' ' ' TRP . 5.0 t -99.46 -67.93 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.913 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.676 ' CD1' HG12 ' A' ' 5' ' ' VAL . 1.0 OUTLIER -103.73 145.62 30.97 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.587 179.776 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.434 ' HG2' HD23 ' A' ' 8' ' ' LEU . 70.4 Cg_endo -89.16 -58.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.598 2.199 . . . . 0.0 113.775 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.434 HD23 ' HG2' ' A' ' 7' ' ' PRO . 0.7 OUTLIER -93.15 -30.63 15.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.74 0.305 . . . . 0.0 111.392 -178.996 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.455 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 16.9 t -52.9 -59.15 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.265 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.425 HG12 ' HB2' ' A' ' 6' ' ' TRP . 28.7 mm -58.65 -48.55 85.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.994 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.23 -18.66 4.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.558 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.1 m -82.72 -49.36 9.85 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.406 ' O ' ' HB2' ' A' ' 17' ' ' TYR . 25.1 t -62.96 -36.24 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.052 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 72.2 mt -61.8 -38.85 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.474 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . . . -62.8 -22.33 66.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.145 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.49 -2.65 22.8 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.231 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.422 ' HA ' ' HB2' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -127.16 1.6 6.46 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.995 0.397 . . . . 0.0 111.636 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.423 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.9 t-20 -142.04 -43.29 0.34 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.646 0.26 . . . . 0.0 111.423 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.41 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 4.3 mt -92.54 18.58 8.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 110.994 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -157.07 -55.34 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.11 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.422 ' HB2' ' HA ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -70.17 -45.6 66.38 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.754 179.733 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -75.26 -38.11 60.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.09 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.2 mm -52.37 -56.31 7.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.323 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.9 mmtm -51.92 -33.61 38.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.081 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -78.93 95.97 5.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.903 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.6 mtm105 . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.812 0.339 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.4 t 61.92 80.7 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.193 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.0 118.23 0.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.787 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.02 155.19 46.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.917 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.456 HG12 ' H ' ' A' ' 6' ' ' TRP . 0.2 OUTLIER -90.2 -163.9 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.374 179.776 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.513 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 1.1 m0 -108.99 99.75 36.84 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 120.75 0.31 . . . . 0.0 110.706 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.85 -36.61 13.16 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.019 2.479 . . . . 0.0 113.582 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.77 -41.55 9.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.721 0.296 . . . . 0.0 111.485 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.513 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 39.7 t -52.7 -66.11 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.093 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.625 HG22 HD11 ' A' ' 14' ' ' ILE . 36.1 mm -55.98 -30.49 28.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.013 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.517 ' HA ' HD12 ' A' ' 14' ' ' ILE . 4.3 ttm-85 -54.39 -20.8 8.07 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.641 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.431 ' CG2' ' N ' ' A' ' 13' ' ' VAL . 1.3 t -82.51 -47.15 12.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.175 0.512 . . . . 0.0 109.714 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.431 ' N ' ' CG2' ' A' ' 12' ' ' THR . 26.4 t -62.64 -34.33 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.783 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.625 HD11 HG22 ' A' ' 10' ' ' ILE . 27.7 mt -70.55 -53.57 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.098 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.4 -25.88 68.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.259 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.723 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -90.29 -8.12 66.73 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.955 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -115.06 -35.7 4.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.853 0.358 . . . . 0.0 111.125 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.601 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 6.8 m-20 -81.52 0.37 38.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.628 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.723 HD23 ' HA2' ' A' ' 16' ' ' GLY . 3.8 pp -77.91 -21.24 51.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.853 0.358 . . . . 0.0 110.871 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -128.46 -51.89 1.27 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.956 0.407 . . . . 0.0 110.593 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.39 -42.72 87.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.065 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -78.64 -51.03 10.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.217 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.5 mm -49.91 -55.16 5.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.33 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -53.54 -30.21 40.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.158 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.3 ttpp -91.34 49.89 1.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.1 mttt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.914 179.95 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.891 0.377 . . . . 0.0 111.173 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 2' ' ' VAL . 9.0 p -138.1 105.3 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.19 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -77.87 149.28 34.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.851 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.38 122.59 45.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.063 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.467 HG12 ' H ' ' A' ' 6' ' ' TRP . 0.2 OUTLIER -92.01 -167.76 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.546 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.652 ' O ' HD12 ' A' ' 10' ' ' ILE . 3.6 m0 -77.73 129.28 77.07 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.648 0.261 . . . . 0.0 110.607 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.787 ' HG2' HD23 ' A' ' 8' ' ' LEU . 66.4 Cg_endo -86.33 -57.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.684 2.256 . . . . 0.0 113.85 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.787 HD23 ' HG2' ' A' ' 7' ' ' PRO . 0.3 OUTLIER -89.56 -30.7 18.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.814 0.34 . . . . 0.0 111.278 -178.975 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 6' ' ' TRP . 12.8 t -55.39 -65.84 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.652 HD12 ' O ' ' A' ' 6' ' ' TRP . 15.0 mt -59.21 -37.8 70.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.985 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.93 -22.28 3.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.588 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.611 HG23 ' O ' ' A' ' 8' ' ' LEU . 18.2 p -78.46 -54.27 6.35 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.9 t -61.24 -34.99 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.11 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.613 ' CG1' HG22 ' A' ' 10' ' ' ILE . 29.8 mm -68.49 -39.07 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.925 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.43 ' O ' HD12 ' A' ' 19' ' ' LEU . . . -80.25 -6.8 58.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.512 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -121.13 -7.55 8.4 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.045 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -143.44 10.83 1.68 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.887 0.344 . . . . 0.0 111.642 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.575 ' HA ' ' HB2' ' A' ' 22' ' ' ALA . 0.2 OUTLIER -137.28 8.75 2.93 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.667 0.27 . . . . 0.0 111.407 179.737 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.466 ' HA ' HD23 ' A' ' 19' ' ' LEU . 13.4 mt -101.28 -32.87 10.29 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.937 0.398 . . . . 0.0 110.427 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -120.53 -49.14 2.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.252 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -48.63 80.94 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.874 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.575 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . . . -59.94 -45.9 91.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.062 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.9 mm -51.4 -41.58 26.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.221 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.4 mtpt -54.16 -34.21 59.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.067 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -77.97 64.2 3.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.849 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.4 mttt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.862 -179.977 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.852 0.358 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.4 m -96.38 -179.6 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.117 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -148.33 122.2 9.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.777 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -58.04 -62.28 1.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.892 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 t -85.38 153.36 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.745 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.48 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -118.04 82.85 18.17 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.741 -179.744 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -63.48 -35.57 59.68 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 123.053 2.502 . . . . 0.0 113.442 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 pp -94.19 -42.2 9.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.901 0.381 . . . . 0.0 111.386 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.48 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 19.5 t -54.3 -59.65 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.091 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.417 HG22 ' CD1' ' A' ' 14' ' ' ILE . 62.9 mt -56.03 -40.73 65.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.972 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.46 -18.33 27.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.374 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.7 m -82.36 -51.55 7.76 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.7 t -58.65 -34.59 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.94 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.417 ' CD1' HG22 ' A' ' 10' ' ' ILE . 97.1 mt -68.73 -53.7 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.847 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.483 ' O ' HD12 ' A' ' 19' ' ' LEU . . . -61.75 -20.76 63.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.325 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.7 -20.78 53.15 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.989 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.6 -38.9 5.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.847 0.356 . . . . 0.0 111.192 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.646 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 3.5 m120 -66.61 -25.7 66.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.028 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 15' ' ' ALA . 10.1 mt -58.09 -19.92 35.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.252 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -114.82 -62.29 1.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.921 0.391 . . . . 0.0 110.814 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -49.54 75.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.441 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -72.41 -52.5 15.67 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.391 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.5 mm -54.85 -53.17 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.972 0.415 . . . . 0.0 111.1 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.92 -29.13 62.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.04 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.3 mmtt -85.76 85.57 7.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.904 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.0 tttt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.875 179.966 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.773 0.321 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -117.22 -38.78 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.165 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.99 -172.68 4.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.899 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.12 149.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.974 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.55 -62.87 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.159 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.467 ' CE3' ' CG1' ' A' ' 9' ' ' VAL . 2.8 m0 -69.34 149.57 97.31 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.821 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -89.73 -57.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.812 2.341 . . . . 0.0 113.885 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.1 pp -92.48 -31.53 15.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.746 0.308 . . . . 0.0 111.469 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.467 ' CG1' ' CE3' ' A' ' 6' ' ' TRP . 18.5 t -53.22 -60.19 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.314 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.705 HG22 HD11 ' A' ' 14' ' ' ILE . 36.5 mm -63.89 -34.95 71.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.795 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.527 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.2 OUTLIER -54.57 -20.12 7.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.421 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -80.67 -52.0 8.05 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.2 t -59.03 -34.69 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.084 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.705 HD11 HG22 ' A' ' 10' ' ' ILE . 30.9 mt -70.01 -40.08 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.84 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.541 ' O ' HD12 ' A' ' 19' ' ' LEU . . . -63.53 -33.7 76.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.034 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.02 -8.51 78.85 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.698 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.443 ' CE2' ' HD3' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -98.31 -65.66 0.95 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.927 0.394 . . . . 0.0 110.974 -179.903 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 5.5 t30 -55.0 -23.35 18.9 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.486 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.541 HD12 ' O ' ' A' ' 15' ' ' ALA . 59.9 mt -85.38 -25.36 27.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.217 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.5 27.18 7.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.957 0.408 . . . . 0.0 111.077 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.443 ' HD3' ' CE2' ' A' ' 17' ' ' TYR . 16.1 ttp85 -146.69 -48.18 0.19 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.267 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -80.77 -34.4 34.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.113 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.5 mm -57.26 -57.55 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.002 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.72 -30.63 33.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.139 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.05 93.51 5.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.88 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.9 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.826 0.346 . . . . 0.0 111.162 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.46 HG23 ' N ' ' A' ' 3' ' ' LYS . 21.4 m -132.84 -44.87 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.159 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.487 ' HE2' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER 64.09 122.5 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.816 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 34.2 mtp180 -143.2 92.61 2.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.976 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.487 HG22 ' HE2' ' A' ' 3' ' ' LYS . 3.4 t -71.61 155.97 7.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.948 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.478 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.9 OUTLIER -111.25 123.3 35.46 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.609 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.78 ' HG2' HD23 ' A' ' 8' ' ' LEU . 65.1 Cg_endo -83.14 -57.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.578 2.185 . . . . 0.0 114.067 -178.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 12' ' ' THR . 0.7 OUTLIER -88.76 -31.22 18.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.761 0.315 . . . . 0.0 111.351 -178.897 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 6' ' ' TRP . 18.8 t -52.92 -65.77 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.319 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.1 mt -56.9 -41.03 75.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.236 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.65 -21.3 10.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.7 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.818 HG23 ' O ' ' A' ' 8' ' ' LEU . 6.1 p -83.54 -48.25 10.46 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.8 t -62.95 -35.0 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.155 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.8 mm -76.17 -38.59 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.087 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.72 ' O ' HD12 ' A' ' 19' ' ' LEU . . . -75.05 -13.97 60.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.44 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.75 -23.19 8.89 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.774 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -97.73 -44.12 6.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.829 0.347 . . . . 0.0 110.997 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.568 ' HA ' ' HB2' ' A' ' 22' ' ' ALA . 48.3 t30 -75.2 -7.24 53.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.47 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.72 HD12 ' O ' ' A' ' 15' ' ' ALA . 16.1 mt -101.63 -26.6 13.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.859 0.361 . . . . 0.0 110.63 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.87 -55.69 2.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.555 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -48.77 80.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.134 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.568 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . . . -60.08 -48.45 81.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.256 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.1 mm -51.47 -48.12 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.239 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.07 -33.3 51.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.182 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -84.75 -32.79 23.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.6 mttm . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.299 -0.858 . . . . 0.0 110.875 -179.868 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.922 0.391 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.4 t -119.25 110.99 31.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.112 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 68.68 -67.38 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.995 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -110.95 156.15 21.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.944 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.12 -60.92 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.118 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.818 ' O ' HD12 ' A' ' 10' ' ' ILE . 1.4 m0 -86.68 110.86 35.56 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.699 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.62 -40.27 1.57 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.815 2.343 . . . . 0.0 113.687 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.577 ' O ' HG23 ' A' ' 12' ' ' THR . 0.4 OUTLIER -98.12 -37.76 9.59 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -178.776 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.486 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 19.3 t -54.47 -61.46 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.873 0.368 . . . . 0.0 111.423 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.818 HD12 ' O ' ' A' ' 6' ' ' TRP . 16.1 mt -57.39 -38.57 63.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.129 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -19.53 10.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.518 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 8' ' ' LEU . 14.2 p -83.28 -49.86 8.97 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.9 t -60.94 -34.72 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.267 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.547 ' CD1' HG22 ' A' ' 10' ' ' ILE . 96.2 mt -66.57 -39.86 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.962 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.551 ' O ' HD12 ' A' ' 19' ' ' LEU . . . -82.0 -0.29 43.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.572 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.25 -13.44 7.61 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.826 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -107.68 -39.67 5.53 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.766 0.317 . . . . 0.0 110.862 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.653 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 5.3 m120 -61.28 -28.2 69.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.855 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.551 HD12 ' O ' ' A' ' 15' ' ' ALA . 7.9 mt -59.45 -19.66 49.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.065 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -125.71 -55.72 1.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.727 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.14 -33.88 69.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.419 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -91.36 -47.68 7.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.335 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.9 mm -55.86 -40.12 60.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.963 0.411 . . . . 0.0 111.104 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -56.14 -34.83 66.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.023 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.7 mtpp -99.89 33.47 2.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.946 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 29.5 ptt85 . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.875 0.369 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.3 t -60.77 149.49 7.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.15 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -104.32 177.47 4.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.752 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.62 -73.19 0.61 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.916 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.688 HG12 ' CD1' ' A' ' 6' ' ' TRP . 5.6 t -151.99 -65.46 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.089 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.784 ' O ' HD12 ' A' ' 10' ' ' ILE . 1.8 m0 -105.65 104.33 47.92 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.664 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -70.88 -38.85 4.87 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.884 2.389 . . . . 0.0 113.775 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.444 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -98.57 -37.91 9.36 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -178.695 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.473 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 21.3 t -54.15 -61.39 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.999 0.428 . . . . 0.0 111.235 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.784 HD12 ' O ' ' A' ' 6' ' ' TRP . 18.8 mt -55.57 -41.33 63.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.002 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.9 ttt85 -59.28 -17.44 28.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.301 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.28 -50.04 8.79 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.424 HG13 ' HD2' ' A' ' 17' ' ' TYR . 39.4 t -59.9 -34.85 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.982 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 68.3 mt -77.89 -37.58 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.927 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.84 9.7 18.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.456 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.491 ' HA2' HD11 ' A' ' 19' ' ' LEU . . . -133.52 -11.92 1.65 Allowed Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.56 -0.829 . . . . 0.0 113.311 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.424 ' HD2' HG13 ' A' ' 13' ' ' VAL . 14.9 m-85 -128.96 -26.96 2.57 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 117.113 0.457 . . . . 0.0 111.437 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.603 ' CG ' ' HB2' ' A' ' 22' ' ' ALA . 0.6 OUTLIER -88.9 15.14 8.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.342 -179.927 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.491 HD11 ' HA2' ' A' ' 16' ' ' GLY . 2.4 mt -84.15 -30.69 25.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.95 0.405 . . . . 0.0 110.597 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -118.39 -52.02 2.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.587 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.42 -48.64 74.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.134 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.603 ' HB2' ' CG ' ' A' ' 18' ' ' ASN . . . -70.6 -53.91 14.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.936 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.0 mm -53.72 -44.79 60.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.095 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -56.73 -35.5 68.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.002 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.43 96.83 10.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.944 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.8 ttpt . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.997 179.936 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.843 0.354 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.4 t -117.13 102.5 13.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.138 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -115.51 163.77 15.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.751 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -168.16 107.88 0.53 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.047 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 6' ' ' TRP . 1.3 t -83.87 174.19 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.577 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.565 ' H ' HG12 ' A' ' 5' ' ' VAL . 2.2 m0 -80.11 132.05 61.07 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.668 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.749 ' HG2' HD23 ' A' ' 8' ' ' LEU . 66.6 Cg_endo -88.37 -57.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.679 2.253 . . . . 0.0 113.828 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.749 HD23 ' HG2' ' A' ' 7' ' ' PRO . 0.3 OUTLIER -91.02 -33.93 15.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.801 0.334 . . . . 0.0 111.28 -179.167 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.515 ' HB ' ' HB3' ' A' ' 6' ' ' TRP . 21.5 t -51.45 -62.57 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.377 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.665 HG22 HD11 ' A' ' 14' ' ' ILE . 30.5 mt -61.18 -34.54 60.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.839 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.85 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -52.1 -21.94 3.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.463 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.1 m -79.29 -52.52 8.01 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.8 t -60.35 -34.63 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.951 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.85 HD12 ' HA ' ' A' ' 11' ' ' ARG . 47.1 mt -61.14 -43.45 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.799 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.487 ' O ' HD12 ' A' ' 19' ' ' LEU . . . -78.31 -0.43 28.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.7 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.08 -13.63 6.39 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.152 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.76 -51.75 0.74 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.86 0.33 . . . . 0.0 111.353 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.628 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 4.6 m-80 -58.41 -20.79 47.35 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.268 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.487 HD12 ' O ' ' A' ' 15' ' ' ALA . 12.3 mt -53.29 -23.22 8.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.177 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -126.1 -56.86 1.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.338 . . . . 0.0 110.797 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.51 -32.87 67.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.379 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -90.25 -48.38 7.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.397 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.615 HD13 ' NZ ' ' A' ' 26' ' ' LYS . 49.1 mm -53.39 -41.7 45.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.189 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.4 -31.51 61.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.029 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -108.64 30.82 6.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.994 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.615 ' NZ ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.913 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 9.4 mtt180 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.982 0.42 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.4 t -136.88 133.58 48.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.003 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.74 -69.74 0.29 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.074 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 14.2 mmt85 56.55 65.08 1.5 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.92 0.391 . . . . 0.0 110.804 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.683 HG12 ' CD1' ' A' ' 6' ' ' TRP . 18.5 t -83.92 -66.58 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.331 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.683 ' CD1' HG12 ' A' ' 5' ' ' VAL . 3.8 m0 -97.48 134.41 22.59 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.895 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.516 ' HG2' HD23 ' A' ' 8' ' ' LEU . 68.2 Cg_endo -90.2 -57.22 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.792 2.328 . . . . 0.0 113.721 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.516 HD23 ' HG2' ' A' ' 7' ' ' PRO . 0.7 OUTLIER -89.12 -31.87 17.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.822 0.344 . . . . 0.0 111.308 -179.125 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.45 ' HB ' ' HB3' ' A' ' 6' ' ' TRP . 17.6 t -52.86 -65.59 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.282 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.869 HG22 HD11 ' A' ' 14' ' ' ILE . 19.5 mt -59.49 -38.31 74.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.15 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.576 ' HA ' HD12 ' A' ' 14' ' ' ILE . 1.6 tpm_? -55.85 -19.85 13.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.505 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -81.16 -51.92 7.91 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.8 t -59.26 -34.47 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.02 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.869 HD11 HG22 ' A' ' 10' ' ' ILE . 40.0 mt -67.78 -51.77 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.002 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.464 ' O ' HD12 ' A' ' 19' ' ' LEU . . . -64.47 -22.61 67.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.437 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.49 -9.82 64.35 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.122 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -116.29 -37.98 3.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.869 0.335 . . . . 0.0 111.192 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.765 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 2.4 m-80 -74.6 -27.2 60.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.144 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 15' ' ' ALA . 10.7 mt -57.9 -20.81 39.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.304 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.424 ' CZ ' ' HE3' ' A' ' 24' ' ' LYS . 1.5 t80 -115.99 -65.69 1.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.372 . . . . 0.0 110.913 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.73 -45.1 74.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.553 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.765 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -73.81 -53.21 10.77 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.274 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.1 mm -55.37 -50.61 64.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.007 0.432 . . . . 0.0 111.128 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.424 ' HE3' ' CZ ' ' A' ' 20' ' ' TYR . 24.6 mmtt -58.21 -30.48 66.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.069 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -60.0 -65.55 0.66 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.1 mtmm . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.89 -179.973 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.775 ' HG3' HG23 ' A' ' 2' ' ' VAL . 1.9 ptt180 . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.832 0.349 . . . . 0.0 111.286 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.775 HG23 ' HG3' ' A' ' 1' ' ' ARG . 21.4 t 63.67 97.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.23 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.61 -65.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.919 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.507 ' HG2' HD13 ' A' ' 10' ' ' ILE . 0.0 OUTLIER 55.4 -168.39 0.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.963 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.0 t -90.47 -55.97 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.068 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.72 ' O ' HD12 ' A' ' 10' ' ' ILE . 1.6 m0 -80.64 114.88 51.42 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.628 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 6' ' ' TRP . 7.3 Cg_exo -73.58 -42.03 0.98 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.693 2.262 . . . . 0.0 113.748 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.897 ' O ' HG23 ' A' ' 12' ' ' THR . 0.5 OUTLIER -101.64 -34.91 9.3 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.702 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.486 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 20.2 t -54.04 -55.21 15.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.974 0.416 . . . . 0.0 111.447 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.72 HD12 ' O ' ' A' ' 6' ' ' TRP . 10.9 mt -68.91 -44.81 81.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.27 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.526 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -53.52 -22.47 8.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.859 -179.415 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.897 HG23 ' O ' ' A' ' 8' ' ' LEU . 50.8 p -82.38 -49.58 9.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.475 HG12 ' HD2' ' A' ' 17' ' ' TYR . 21.4 t -64.38 -35.13 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.113 178.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.526 ' CG1' HG22 ' A' ' 10' ' ' ILE . 36.3 mm -78.01 -37.5 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.101 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.703 ' HA ' HD12 ' A' ' 19' ' ' LEU . . . -61.5 -23.04 65.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.509 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.85 -7.52 29.19 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.602 -0.809 . . . . 0.0 113.313 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.475 ' HD2' HG12 ' A' ' 13' ' ' VAL . 10.3 m-85 -115.85 -22.09 9.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.904 0.352 . . . . 0.0 111.574 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -117.74 -28.87 5.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.577 0.227 . . . . 0.0 111.367 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.703 HD12 ' HA ' ' A' ' 15' ' ' ALA . 5.9 mt -97.84 25.85 5.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.879 0.371 . . . . 0.0 110.675 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -163.34 -59.88 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.224 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -43.3 74.93 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.995 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.94 -49.27 25.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.246 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.422 HD11 ' HA ' ' A' ' 19' ' ' LEU . 35.3 mt -51.51 -59.97 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.009 0.433 . . . . 0.0 111.131 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -53.46 -25.31 15.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.171 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -93.19 44.6 1.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.937 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.013 179.969 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.804 0.335 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.8 m -99.17 125.82 52.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.076 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -152.8 -46.46 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 68.4 mtm180 -140.54 109.94 6.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.026 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.483 HG12 ' CD1' ' A' ' 6' ' ' TRP . 21.9 t -110.81 -65.22 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.011 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.483 ' CD1' HG12 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -93.49 147.29 33.41 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.695 179.812 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.823 ' HG2' HD23 ' A' ' 8' ' ' LEU . 70.8 Cg_endo -89.12 -58.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.783 2.322 . . . . 0.0 113.944 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.823 HD23 ' HG2' ' A' ' 7' ' ' PRO . 0.4 OUTLIER -93.58 -34.02 13.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.768 0.318 . . . . 0.0 111.293 -179.039 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.456 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 39.8 t -49.79 -57.4 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.558 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.854 HG22 HD11 ' A' ' 14' ' ' ILE . 78.2 mt -65.74 -44.46 93.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.147 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.747 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -51.88 -21.58 3.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.649 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.47 -50.27 9.62 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.431 HG12 ' CD1' ' A' ' 17' ' ' TYR . 36.0 t -61.91 -35.24 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.947 178.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.854 HD11 HG22 ' A' ' 10' ' ' ILE . 51.6 mt -61.25 -43.12 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.739 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.505 ' O ' HD12 ' A' ' 19' ' ' LEU . . . -60.38 -24.52 65.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.102 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -112.27 15.36 25.3 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.875 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.431 ' CD1' HG12 ' A' ' 13' ' ' VAL . 0.6 OUTLIER -118.89 -41.78 2.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.891 0.377 . . . . 0.0 110.963 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.554 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 20.7 t-20 -73.55 -9.24 58.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.356 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.505 HD12 ' O ' ' A' ' 15' ' ' ALA . 28.6 mt -85.06 -17.98 35.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.797 0.332 . . . . 0.0 111.325 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -123.84 -59.18 1.53 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.835 0.35 . . . . 0.0 110.81 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.67 -45.15 73.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.39 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -75.72 -52.03 11.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.068 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.6 mm -51.82 -41.63 30.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.172 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -55.18 -34.56 63.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.091 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -66.29 -33.08 74.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.916 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.295 -0.859 . . . . 0.0 110.871 179.959 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.819 0.342 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.7 m -76.53 149.71 6.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.15 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -113.7 -57.49 2.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.875 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -82.62 116.2 21.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.811 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.714 HG12 ' CD1' ' A' ' 6' ' ' TRP . 9.7 t -127.52 -65.87 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.993 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.714 ' CD1' HG12 ' A' ' 5' ' ' VAL . 1.9 m0 -104.36 141.18 22.0 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.59 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -89.54 -58.57 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.684 2.256 . . . . 0.0 113.684 -179.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.892 ' O ' HG23 ' A' ' 12' ' ' THR . 2.9 pp -93.09 -30.94 15.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.791 0.329 . . . . 0.0 111.372 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.471 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 21.3 t -50.08 -57.98 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.427 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.912 HG22 HD11 ' A' ' 14' ' ' ILE . 23.0 mt -66.55 -40.14 85.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.244 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.3 tpt85 -56.33 -20.09 17.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.653 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.892 HG23 ' O ' ' A' ' 8' ' ' LEU . 21.4 p -82.94 -49.71 9.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.347 0.594 . . . . 0.0 109.451 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.545 HG13 ' CD2' ' A' ' 17' ' ' TYR . 26.2 t -60.81 -34.64 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.138 178.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.912 HD11 HG22 ' A' ' 10' ' ' ILE . 43.5 mt -73.02 -38.15 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.265 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.477 ' O ' HD12 ' A' ' 19' ' ' LEU . . . -85.15 5.35 30.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.592 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.12 -22.78 1.09 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.456 -0.878 . . . . 0.0 113.238 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.545 ' CD2' HG13 ' A' ' 13' ' ' VAL . 93.0 m-85 -119.23 -30.09 5.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 117.035 0.417 . . . . 0.0 111.601 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.675 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.4 m-20 -84.34 5.56 26.48 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.477 HD12 ' O ' ' A' ' 15' ' ' ALA . 5.2 mt -79.96 -9.71 59.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.712 0.291 . . . . 0.0 111.029 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.98 -60.24 0.97 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.886 0.374 . . . . 0.0 110.634 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -43.4 83.2 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.238 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -76.27 -50.9 13.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.217 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.0 mm -47.5 -62.9 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.34 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -53.63 -30.31 42.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.013 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.68 -62.22 1.57 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.945 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.727 ' O ' HD12 ' A' ' 10' ' ' ILE . 1.0 OUTLIER . . . . . 0 CA--C 1.53 0.209 0 CA-C-O 120.494 0.188 . . . . 0.0 110.544 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 6' ' ' TRP . 3.0 Cg_exo -75.61 -41.92 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.772 2.315 . . . . 0.0 113.591 -178.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.8 ' O ' HG23 ' A' ' 12' ' ' THR . 3.3 pp -98.93 -37.09 9.54 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.466 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 19.7 t -52.25 -59.5 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.905 0.384 . . . . 0.0 111.473 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.727 HD12 ' O ' ' A' ' 6' ' ' TRP . 24.8 mt -58.87 -43.69 88.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.266 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.5 ttt180 -55.13 -20.59 10.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.809 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.8 HG23 ' O ' ' A' ' 8' ' ' LEU . 4.7 p -82.59 -50.08 9.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.213 0.53 . . . . 0.0 109.596 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.8 t -65.71 -35.03 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.35 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.553 HG23 ' HB3' ' A' ' 18' ' ' ASN . 34.4 mm . . . . . 0 N--CA 1.45 -0.47 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.175 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.553 ' HB3' HG23 ' A' ' 14' ' ' ILE . 5.6 t30 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.578 0.228 . . . . 0.0 111.505 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 mt -94.85 -30.08 14.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.948 0.404 . . . . 0.0 110.586 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -124.31 -49.91 1.79 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.692 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -59.5 -43.65 93.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.059 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.409 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . . . -73.19 -53.72 10.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.242 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.4 mm -50.7 -55.74 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.178 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.6 mttp -55.73 -25.05 38.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.224 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-O 120.891 0.377 . . . . 0.0 110.927 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.515 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 2.3 m0 . . . . . 0 CA--C 1.53 0.18 0 CA-C-O 120.52 0.2 . . . . 0.0 110.608 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 6' ' ' TRP . 7.5 Cg_exo -73.71 -40.51 1.43 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.739 2.293 . . . . 0.0 113.614 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.17 -36.55 8.9 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.515 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 20.6 t -55.68 -56.96 9.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.851 0.358 . . . . 0.0 111.272 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.441 HG12 ' HB2' ' A' ' 6' ' ' TRP . 36.8 mm -54.56 -43.67 65.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.915 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.64 -20.33 13.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.492 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.6 m -80.55 -53.14 6.84 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.5 t -62.01 -35.2 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.169 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.3 mm . . . . . 0 N--CA 1.449 -0.5 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.095 179.888 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.436 ' HA ' ' CB ' ' A' ' 22' ' ' ALA . 46.5 t30 . . . . . 0 CA--C 1.528 0.119 0 CA-C-O 120.596 0.236 . . . . 0.0 111.563 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 87.7 mt -104.71 24.02 12.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.002 0.43 . . . . 0.0 110.811 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -170.0 -59.96 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.304 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -64.56 -39.67 94.18 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.793 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.436 ' CB ' ' HA ' ' A' ' 18' ' ' ASN . . . -76.66 -44.2 34.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.6 mt -51.46 -54.73 10.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.115 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.2 pttm -55.08 -31.41 61.16 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.101 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.964 -179.912 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.823 ' O ' HD12 ' A' ' 10' ' ' ILE . 2.9 m0 . . . . . 0 CA--C 1.53 0.191 0 CA-C-O 120.508 0.194 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -73.64 -39.82 1.76 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.894 2.396 . . . . 0.0 113.599 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.77 -38.68 9.38 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.481 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 21.0 t -53.89 -61.98 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.872 0.367 . . . . 0.0 111.259 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.823 HD12 ' O ' ' A' ' 6' ' ' TRP . 19.1 mt -55.51 -40.01 56.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.986 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.635 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -57.88 -18.83 25.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.274 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.6 m -81.79 -51.51 8.07 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 39.5 t -59.94 -34.86 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.044 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.823 HD11 HG22 ' A' ' 10' ' ' ILE . 45.2 mt . . . . . 0 N--CA 1.452 -0.33 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.882 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.522 ' ND2' HG22 ' A' ' 14' ' ' ILE . 55.9 p30 . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.985 HD22 HD11 ' A' ' 23' ' ' ILE . 7.5 mt -104.6 -55.88 2.27 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.848 0.356 . . . . 0.0 110.534 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -56.53 -60.39 3.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.537 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.9 ttm180 -58.76 -52.11 67.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.059 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -58.47 -59.15 5.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.182 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.985 HD11 HD22 ' A' ' 19' ' ' LEU . 66.9 mt -51.44 -45.42 34.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.897 0.379 . . . . 0.0 110.954 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.24 -33.84 65.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.933 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.5 tttm . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 179.996 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.639 ' O ' HD12 ' A' ' 10' ' ' ILE . 2.1 m0 . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.561 0.22 . . . . 0.0 110.7 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -72.41 -39.6 2.72 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.724 2.283 . . . . 0.0 113.807 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.74 -37.14 8.85 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.472 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 22.9 t -55.47 -58.23 5.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.867 0.365 . . . . 0.0 111.268 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.948 HG22 HD11 ' A' ' 14' ' ' ILE . 15.6 mt -64.01 -40.82 90.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.204 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -57.25 -21.06 31.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.613 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.15 -48.22 10.07 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.9 t -61.03 -34.1 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.997 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.948 HD11 HG22 ' A' ' 10' ' ' ILE . 43.2 mt . . . . . 0 N--CA 1.451 -0.391 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.135 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.507 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 33.5 m-20 . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 120.613 0.244 . . . . 0.0 111.419 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.64 -21.22 30.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.811 0.339 . . . . 0.0 110.799 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -127.51 -54.91 1.34 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.651 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.68 -42.23 78.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.334 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -77.98 -50.54 11.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.289 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.5 mm -50.17 -52.54 14.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.421 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.1 pttm -53.39 -33.03 52.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.063 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.7 tptm . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.815 -179.874 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.448 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 5.3 m0 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.599 0.238 . . . . 0.0 110.69 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.841 ' HG2' HD23 ' A' ' 8' ' ' LEU . 68.6 Cg_endo -87.04 -58.53 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.659 2.239 . . . . 0.0 113.751 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.907 ' O ' HG23 ' A' ' 12' ' ' THR . 0.5 OUTLIER -95.78 -33.49 12.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.71 0.29 . . . . 0.0 111.428 -179.147 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.448 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 22.0 t -49.31 -53.07 9.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.895 0.378 . . . . 0.0 111.536 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.426 HG22 ' CG1' ' A' ' 14' ' ' ILE . 29.7 mm -71.44 -46.41 64.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.082 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.6 tpt85 -51.71 -22.91 3.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.663 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.907 HG23 ' O ' ' A' ' 8' ' ' LEU . 43.2 p -81.31 -50.52 9.41 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.1 t -63.41 -35.23 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.123 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.426 ' CG1' HG22 ' A' ' 10' ' ' ILE . 32.1 mm . . . . . 0 N--CA 1.453 -0.319 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.017 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.44 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 8.3 m-20 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.6 0.238 . . . . 0.0 111.274 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.701 HD12 ' N ' ' A' ' 20' ' ' TYR . 0.3 OUTLIER -87.13 -17.49 32.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.869 179.715 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.701 ' N ' HD12 ' A' ' 19' ' ' LEU . 10.7 t80 -131.84 -51.05 0.97 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.584 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -58.24 -43.5 87.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.857 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -77.93 -50.85 11.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.186 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.4 mm -50.48 -47.34 27.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.268 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.0 mmtm -53.89 -32.76 54.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.077 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.906 -179.924 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.527 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 3.5 m0 . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 120.761 0.315 . . . . 0.0 110.53 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -64.9 -35.81 42.39 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.988 2.459 . . . . 0.0 113.798 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.84 -38.73 8.93 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.527 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 42.0 t -55.72 -59.55 2.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.927 0.394 . . . . 0.0 111.26 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.895 HG22 HD11 ' A' ' 14' ' ' ILE . 42.4 mm -54.42 -38.62 41.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.191 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.457 ' HA ' HD12 ' A' ' 14' ' ' ILE . 16.1 ttp-105 -55.97 -19.28 11.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.576 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.6 p -82.18 -51.34 8.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.334 0.587 . . . . 0.0 109.547 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.4 t -61.51 -34.99 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.286 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.895 HD11 HG22 ' A' ' 10' ' ' ILE . 46.8 mt . . . . . 0 N--CA 1.451 -0.383 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.016 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.466 ' HB2' HG23 ' A' ' 14' ' ' ILE . 3.4 m-20 . . . . . 0 CA--C 1.529 0.158 0 N-CA-C 111.598 0.221 . . . . 0.0 111.598 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.739 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.9 OUTLIER -88.49 -19.56 26.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.854 0.359 . . . . 0.0 110.785 179.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.511 ' CD2' HD12 ' A' ' 19' ' ' LEU . 10.7 m-85 -129.48 -50.2 1.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.494 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.58 -45.34 94.53 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.28 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -72.75 -53.43 11.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.231 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.739 HD12 ' O ' ' A' ' 19' ' ' LEU . 28.8 mt -53.83 -38.66 36.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.997 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.3 mmtm -57.19 -35.76 69.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.954 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.936 179.955 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.531 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 0.6 OUTLIER . . . . . 0 CA--C 1.53 0.18 0 CA-C-O 120.617 0.246 . . . . 0.0 110.595 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.53 -37.97 15.66 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.871 2.381 . . . . 0.0 113.938 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.42 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.6 OUTLIER -102.99 -35.72 8.46 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.519 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.531 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 38.4 t -56.59 -51.39 66.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.86 0.362 . . . . 0.0 111.267 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.447 HG22 ' CG1' ' A' ' 14' ' ' ILE . 50.7 mm -57.97 -49.18 82.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.157 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.3 ttt-85 -52.92 -22.32 5.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.459 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.2 m -82.12 -49.89 9.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.316 0.579 . . . . 0.0 109.497 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.9 t -64.63 -35.43 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.234 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.447 ' CG1' HG22 ' A' ' 10' ' ' ILE . 27.4 mm . . . . . 0 N--CA 1.452 -0.326 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.842 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.615 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 2.5 m-80 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.721 0.296 . . . . 0.0 111.393 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.653 ' O ' HD12 ' A' ' 23' ' ' ILE . 3.3 pp -90.32 -22.94 21.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.838 0.351 . . . . 0.0 110.679 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -121.81 -54.39 1.94 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.518 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -48.39 81.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.268 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -65.99 -56.06 13.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.357 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.653 HD12 ' O ' ' A' ' 19' ' ' LEU . 16.6 mt -53.13 -48.29 53.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.907 0.384 . . . . 0.0 111.174 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -33.25 67.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.026 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.903 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.455 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.575 0.226 . . . . 0.0 110.587 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.434 ' HG2' HD23 ' A' ' 8' ' ' LEU . 70.4 Cg_endo -89.16 -58.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.598 2.199 . . . . 0.0 113.775 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.434 HD23 ' HG2' ' A' ' 7' ' ' PRO . 0.7 OUTLIER -93.15 -30.63 15.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.74 0.305 . . . . 0.0 111.392 -178.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.455 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 16.9 t -52.9 -59.15 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.265 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.425 HG12 ' HB2' ' A' ' 6' ' ' TRP . 28.7 mm -58.65 -48.55 85.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.994 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.23 -18.66 4.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.558 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.1 m -82.72 -49.36 9.85 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.1 t -62.96 -36.24 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.052 178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 72.2 mt . . . . . 0 N--CA 1.451 -0.376 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.474 179.465 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.423 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.9 t-20 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.646 0.26 . . . . 0.0 111.423 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 mt -92.54 18.58 8.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 110.994 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -157.07 -55.34 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.11 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.17 -45.6 66.38 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.754 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -75.26 -38.11 60.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.09 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.2 mm -52.37 -56.31 7.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.323 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.9 mmtm -51.92 -33.61 38.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.081 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.2 mttt . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 -179.905 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.513 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 1.1 m0 . . . . . 0 CA--C 1.53 0.186 0 CA-C-O 120.75 0.31 . . . . 0.0 110.706 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.85 -36.61 13.16 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.019 2.479 . . . . 0.0 113.582 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.77 -41.55 9.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.721 0.296 . . . . 0.0 111.485 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.513 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 39.7 t -52.7 -66.11 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.093 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.625 HG22 HD11 ' A' ' 14' ' ' ILE . 36.1 mm -55.98 -30.49 28.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.013 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.517 ' HA ' HD12 ' A' ' 14' ' ' ILE . 4.3 ttm-85 -54.39 -20.8 8.07 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.641 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.431 ' CG2' ' N ' ' A' ' 13' ' ' VAL . 1.3 t -82.51 -47.15 12.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.175 0.512 . . . . 0.0 109.714 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.431 ' N ' ' CG2' ' A' ' 12' ' ' THR . 26.4 t -62.64 -34.33 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.783 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.625 HD11 HG22 ' A' ' 10' ' ' ILE . 27.7 mt . . . . . 0 N--CA 1.449 -0.483 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.098 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.601 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 6.8 m-20 . . . . . 0 CA--C 1.53 0.179 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.8 pp -77.91 -21.24 51.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.853 0.358 . . . . 0.0 110.871 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -128.46 -51.89 1.27 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.956 0.407 . . . . 0.0 110.593 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.39 -42.72 87.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.065 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -78.64 -51.03 10.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.217 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.5 mm -49.91 -55.16 5.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.33 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -53.54 -30.21 40.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.158 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.3 ttpp . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 -179.905 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.652 ' O ' HD12 ' A' ' 10' ' ' ILE . 3.6 m0 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.648 0.261 . . . . 0.0 110.607 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.787 ' HG2' HD23 ' A' ' 8' ' ' LEU . 66.4 Cg_endo -86.33 -57.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.684 2.256 . . . . 0.0 113.85 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.787 HD23 ' HG2' ' A' ' 7' ' ' PRO . 0.3 OUTLIER -89.56 -30.7 18.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.814 0.34 . . . . 0.0 111.278 -178.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 6' ' ' TRP . 12.8 t -55.39 -65.84 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.652 HD12 ' O ' ' A' ' 6' ' ' TRP . 15.0 mt -59.21 -37.8 70.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.985 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.93 -22.28 3.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.588 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.611 HG23 ' O ' ' A' ' 8' ' ' LEU . 18.2 p -78.46 -54.27 6.35 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.9 t -61.24 -34.99 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.11 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.613 ' CG1' HG22 ' A' ' 10' ' ' ILE . 29.8 mm . . . . . 0 N--CA 1.451 -0.384 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.925 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.575 ' HA ' ' HB2' ' A' ' 22' ' ' ALA . 3.5 t-20 . . . . . 0 CA--C 1.528 0.111 0 CA-C-O 120.667 0.27 . . . . 0.0 111.407 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.466 ' HA ' HD23 ' A' ' 19' ' ' LEU . 13.4 mt -101.28 -32.87 10.29 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.937 0.398 . . . . 0.0 110.427 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -120.53 -49.14 2.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.252 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -48.63 80.94 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.874 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.575 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . . . -59.94 -45.9 91.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.062 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.9 mm -51.4 -41.58 26.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.221 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.4 mtpt -54.16 -34.21 59.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.067 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.849 179.973 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.48 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.793 0.33 . . . . 0.0 110.741 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -63.48 -35.57 59.68 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 123.053 2.502 . . . . 0.0 113.442 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 pp -94.19 -42.2 9.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.901 0.381 . . . . 0.0 111.386 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.48 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 19.5 t -54.3 -59.65 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.091 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.417 HG22 ' CD1' ' A' ' 14' ' ' ILE . 62.9 mt -56.03 -40.73 65.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.972 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.46 -18.33 27.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.374 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.7 m -82.36 -51.55 7.76 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.7 t -58.65 -34.59 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.94 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.417 ' CD1' HG22 ' A' ' 10' ' ' ILE . 97.1 mt . . . . . 0 N--CA 1.451 -0.423 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.847 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.646 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 3.5 m120 . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.77 0.319 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.1 mt -58.09 -19.92 35.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.252 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -114.82 -62.29 1.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.921 0.391 . . . . 0.0 110.814 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -49.54 75.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.441 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -72.41 -52.5 15.67 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.391 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.5 mm -54.85 -53.17 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.972 0.415 . . . . 0.0 111.1 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.92 -29.13 62.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.04 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.3 mmtt . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.904 179.957 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.467 ' CE3' ' CG1' ' A' ' 9' ' ' VAL . 2.8 m0 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.587 0.232 . . . . 0.0 110.821 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -89.73 -57.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.812 2.341 . . . . 0.0 113.885 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.1 pp -92.48 -31.53 15.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.746 0.308 . . . . 0.0 111.469 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.467 ' CG1' ' CE3' ' A' ' 6' ' ' TRP . 18.5 t -53.22 -60.19 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.314 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.705 HG22 HD11 ' A' ' 14' ' ' ILE . 36.5 mm -63.89 -34.95 71.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.795 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.527 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.2 OUTLIER -54.57 -20.12 7.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.421 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -80.67 -52.0 8.05 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.2 t -59.03 -34.69 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.084 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.705 HD11 HG22 ' A' ' 10' ' ' ILE . 30.9 mt . . . . . 0 N--CA 1.452 -0.342 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.84 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 5.5 t30 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.684 0.278 . . . . 0.0 111.486 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 59.9 mt -85.38 -25.36 27.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.217 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.5 27.18 7.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.957 0.408 . . . . 0.0 111.077 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 16.1 ttp85 -146.69 -48.18 0.19 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.267 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -80.77 -34.4 34.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.113 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.5 mm -57.26 -57.55 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.002 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.72 -30.63 33.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.139 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.88 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.478 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.9 OUTLIER . . . . . 0 CA--C 1.531 0.225 0 CA-C-O 120.542 0.211 . . . . 0.0 110.609 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.78 ' HG2' HD23 ' A' ' 8' ' ' LEU . 65.1 Cg_endo -83.14 -57.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.578 2.185 . . . . 0.0 114.067 -178.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 12' ' ' THR . 0.7 OUTLIER -88.76 -31.22 18.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.761 0.315 . . . . 0.0 111.351 -178.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 6' ' ' TRP . 18.8 t -52.92 -65.77 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.319 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.1 mt -56.9 -41.03 75.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.236 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.65 -21.3 10.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.7 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.818 HG23 ' O ' ' A' ' 8' ' ' LEU . 6.1 p -83.54 -48.25 10.46 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.8 t -62.95 -35.0 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.155 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.8 mm . . . . . 0 N--CA 1.45 -0.46 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.087 179.942 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.568 ' HA ' ' HB2' ' A' ' 22' ' ' ALA . 48.3 t30 . . . . . 0 CA--C 1.528 0.13 0 CA-C-O 120.583 0.23 . . . . 0.0 111.47 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 19' ' ' LEU . 16.1 mt -101.63 -26.6 13.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.859 0.361 . . . . 0.0 110.63 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.87 -55.69 2.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.555 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -48.77 80.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.134 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.568 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . . . -60.08 -48.45 81.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.256 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.1 mm -51.47 -48.12 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.239 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.07 -33.3 51.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.182 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 179.984 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.818 ' O ' HD12 ' A' ' 10' ' ' ILE . 1.4 m0 . . . . . 0 CA--C 1.531 0.212 0 CA-C-O 120.498 0.19 . . . . 0.0 110.699 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.62 -40.27 1.57 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.815 2.343 . . . . 0.0 113.687 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.577 ' O ' HG23 ' A' ' 12' ' ' THR . 0.4 OUTLIER -98.12 -37.76 9.59 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -178.776 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.486 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 19.3 t -54.47 -61.46 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.873 0.368 . . . . 0.0 111.423 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.818 HD12 ' O ' ' A' ' 6' ' ' TRP . 16.1 mt -57.39 -38.57 63.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.129 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -19.53 10.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.518 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 8' ' ' LEU . 14.2 p -83.28 -49.86 8.97 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.9 t -60.94 -34.72 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.267 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.547 ' CD1' HG22 ' A' ' 10' ' ' ILE . 96.2 mt . . . . . 0 N--CA 1.451 -0.379 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.962 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.653 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 5.3 m120 . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 120.825 0.345 . . . . 0.0 110.855 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.9 mt -59.45 -19.66 49.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.065 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -125.71 -55.72 1.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.727 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.14 -33.88 69.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.419 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -91.36 -47.68 7.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.335 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.9 mm -55.86 -40.12 60.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.963 0.411 . . . . 0.0 111.104 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -56.14 -34.83 66.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.023 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.7 mtpp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.927 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.784 ' O ' HD12 ' A' ' 10' ' ' ILE . 1.8 m0 . . . . . 0 CA--C 1.529 0.155 0 CA-C-O 120.64 0.257 . . . . 0.0 110.664 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -70.88 -38.85 4.87 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.884 2.389 . . . . 0.0 113.775 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.444 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -98.57 -37.91 9.36 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -178.695 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.473 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 21.3 t -54.15 -61.39 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.999 0.428 . . . . 0.0 111.235 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.784 HD12 ' O ' ' A' ' 6' ' ' TRP . 18.8 mt -55.57 -41.33 63.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.002 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.9 ttt85 -59.28 -17.44 28.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.301 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.28 -50.04 8.79 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 39.4 t -59.9 -34.85 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.982 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 68.3 mt . . . . . 0 N--CA 1.449 -0.511 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.927 179.813 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.603 ' CG ' ' HB2' ' A' ' 22' ' ' ALA . 0.6 OUTLIER . . . . . 0 CA--C 1.53 0.199 0 CA-C-O 120.471 0.177 . . . . 0.0 111.342 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 mt -84.15 -30.69 25.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.95 0.405 . . . . 0.0 110.597 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -118.39 -52.02 2.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.587 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.42 -48.64 74.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.134 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.603 ' HB2' ' CG ' ' A' ' 18' ' ' ASN . . . -70.6 -53.91 14.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.936 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.0 mm -53.72 -44.79 60.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.095 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -56.73 -35.5 68.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.002 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.944 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.515 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 2.2 m0 . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 120.538 0.208 . . . . 0.0 110.668 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.749 ' HG2' HD23 ' A' ' 8' ' ' LEU . 66.6 Cg_endo -88.37 -57.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.679 2.253 . . . . 0.0 113.828 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.749 HD23 ' HG2' ' A' ' 7' ' ' PRO . 0.3 OUTLIER -91.02 -33.93 15.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.801 0.334 . . . . 0.0 111.28 -179.167 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.515 ' HB ' ' HB3' ' A' ' 6' ' ' TRP . 21.5 t -51.45 -62.57 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.377 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.665 HG22 HD11 ' A' ' 14' ' ' ILE . 30.5 mt -61.18 -34.54 60.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.839 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.85 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -52.1 -21.94 3.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.463 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.1 m -79.29 -52.52 8.01 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.8 t -60.35 -34.63 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.951 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.85 HD12 ' HA ' ' A' ' 11' ' ' ARG . 47.1 mt . . . . . 0 N--CA 1.453 -0.323 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.799 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.628 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 4.6 m-80 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.672 0.272 . . . . 0.0 111.268 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 19' ' ' LEU . 12.3 mt -53.29 -23.22 8.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.177 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -126.1 -56.86 1.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.338 . . . . 0.0 110.797 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.51 -32.87 67.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.379 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -90.25 -48.38 7.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.397 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.1 mm -53.39 -41.7 45.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.189 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.4 -31.51 61.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.029 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.994 -179.993 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.57 ' O ' HD12 ' A' ' 10' ' ' ILE . 3.8 m0 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.521 0.2 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.516 ' HG2' HD23 ' A' ' 8' ' ' LEU . 68.2 Cg_endo -90.2 -57.22 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.792 2.328 . . . . 0.0 113.721 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.516 HD23 ' HG2' ' A' ' 7' ' ' PRO . 0.7 OUTLIER -89.12 -31.87 17.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.822 0.344 . . . . 0.0 111.308 -179.125 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.45 ' HB ' ' HB3' ' A' ' 6' ' ' TRP . 17.6 t -52.86 -65.59 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.282 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.869 HG22 HD11 ' A' ' 14' ' ' ILE . 19.5 mt -59.49 -38.31 74.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.15 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.576 ' HA ' HD12 ' A' ' 14' ' ' ILE . 1.6 tpm_? -55.85 -19.85 13.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.505 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -81.16 -51.92 7.91 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.8 t -59.26 -34.47 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.02 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.869 HD11 HG22 ' A' ' 10' ' ' ILE . 40.0 mt . . . . . 0 N--CA 1.451 -0.386 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.002 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.765 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 2.4 m-80 . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.785 0.326 . . . . 0.0 111.144 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 19' ' ' LEU . 10.7 mt -57.9 -20.81 39.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.304 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.424 ' CZ ' ' HE3' ' A' ' 24' ' ' LYS . 1.5 t80 -115.99 -65.69 1.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.372 . . . . 0.0 110.913 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.73 -45.1 74.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.553 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.765 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -73.81 -53.21 10.77 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.274 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.1 mm -55.37 -50.61 64.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.007 0.432 . . . . 0.0 111.128 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.424 ' HE3' ' CZ ' ' A' ' 20' ' ' TYR . 24.6 mmtt -58.21 -30.48 66.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.069 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.3 mttp . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.917 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.72 ' O ' HD12 ' A' ' 10' ' ' ILE . 1.6 m0 . . . . . 0 CA--C 1.531 0.231 0 CA-C-O 120.507 0.194 . . . . 0.0 110.628 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 6' ' ' TRP . 7.3 Cg_exo -73.58 -42.03 0.98 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.693 2.262 . . . . 0.0 113.748 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.897 ' O ' HG23 ' A' ' 12' ' ' THR . 0.5 OUTLIER -101.64 -34.91 9.3 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.702 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.486 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 20.2 t -54.04 -55.21 15.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.974 0.416 . . . . 0.0 111.447 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.72 HD12 ' O ' ' A' ' 6' ' ' TRP . 10.9 mt -68.91 -44.81 81.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.27 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.52 -22.47 8.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.859 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.897 HG23 ' O ' ' A' ' 8' ' ' LEU . 50.8 p -82.38 -49.58 9.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -64.38 -35.13 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.113 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.526 ' CG1' HG22 ' A' ' 10' ' ' ILE . 36.3 mm . . . . . 0 N--CA 1.45 -0.444 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.101 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.577 0.227 . . . . 0.0 111.367 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.422 ' HA ' HD11 ' A' ' 23' ' ' ILE . 5.9 mt -97.84 25.85 5.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.879 0.371 . . . . 0.0 110.675 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -163.34 -59.88 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.224 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -43.3 74.93 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.995 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.94 -49.27 25.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.246 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.422 HD11 ' HA ' ' A' ' 19' ' ' LEU . 35.3 mt -51.51 -59.97 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.009 0.433 . . . . 0.0 111.131 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -53.46 -25.31 15.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.171 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.937 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.456 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.621 0.248 . . . . 0.0 110.695 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.823 ' HG2' HD23 ' A' ' 8' ' ' LEU . 70.8 Cg_endo -89.12 -58.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.783 2.322 . . . . 0.0 113.944 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.823 HD23 ' HG2' ' A' ' 7' ' ' PRO . 0.4 OUTLIER -93.58 -34.02 13.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.768 0.318 . . . . 0.0 111.293 -179.039 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.456 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 39.8 t -49.79 -57.4 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.558 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.854 HG22 HD11 ' A' ' 14' ' ' ILE . 78.2 mt -65.74 -44.46 93.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.147 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.747 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -51.88 -21.58 3.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.649 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.47 -50.27 9.62 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.0 t -61.91 -35.24 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.947 178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.854 HD11 HG22 ' A' ' 10' ' ' ILE . 51.6 mt . . . . . 0 N--CA 1.454 -0.271 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.739 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.554 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 20.7 t-20 . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 120.59 0.233 . . . . 0.0 111.356 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.6 mt -85.06 -17.98 35.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.797 0.332 . . . . 0.0 111.325 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -123.84 -59.18 1.53 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.835 0.35 . . . . 0.0 110.81 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.67 -45.15 73.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.39 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -75.72 -52.03 11.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.068 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.6 mm -51.82 -41.63 30.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.172 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -55.18 -34.56 63.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.091 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.916 -179.982 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.471 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 1.9 m0 . . . . . 0 CA--C 1.528 0.105 0 CA-C-O 120.562 0.22 . . . . 0.0 110.59 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -89.54 -58.57 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.684 2.256 . . . . 0.0 113.684 -179.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.892 ' O ' HG23 ' A' ' 12' ' ' THR . 2.9 pp -93.09 -30.94 15.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.791 0.329 . . . . 0.0 111.372 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.471 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 21.3 t -50.08 -57.98 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.427 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.912 HG22 HD11 ' A' ' 14' ' ' ILE . 23.0 mt -66.55 -40.14 85.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.244 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.3 tpt85 -56.33 -20.09 17.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.653 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.892 HG23 ' O ' ' A' ' 8' ' ' LEU . 21.4 p -82.94 -49.71 9.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.347 0.594 . . . . 0.0 109.451 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.2 t -60.81 -34.64 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.138 178.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.912 HD11 HG22 ' A' ' 10' ' ' ILE . 43.5 mt . . . . . 0 N--CA 1.449 -0.487 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.265 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.675 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.4 m-20 . . . . . 0 CA--C 1.529 0.161 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 mt -79.96 -9.71 59.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.712 0.291 . . . . 0.0 111.029 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.98 -60.24 0.97 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.886 0.374 . . . . 0.0 110.634 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -43.4 83.2 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.238 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -76.27 -50.9 13.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.217 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.0 mm -47.5 -62.9 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.34 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -53.63 -30.31 42.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.013 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.788 0.327 . . . . 0.0 111.158 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.1 m -71.16 157.44 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.145 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.1 -30.3 7.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.912 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -167.49 111.01 0.67 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.843 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.731 HG12 ' CD1' ' A' ' 6' ' ' TRP . 2.7 t -106.59 -68.61 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.078 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.731 ' CD1' HG12 ' A' ' 5' ' ' VAL . 1.0 OUTLIER -111.29 111.18 55.6 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.544 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 6' ' ' TRP . 3.0 Cg_exo -75.61 -41.92 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.772 2.315 . . . . 0.0 113.591 -178.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.8 ' O ' HG23 ' A' ' 12' ' ' THR . 3.3 pp -98.93 -37.09 9.54 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.466 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 19.7 t -52.25 -59.5 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.905 0.384 . . . . 0.0 111.473 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.727 HD12 ' O ' ' A' ' 6' ' ' TRP . 24.8 mt -58.87 -43.69 88.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.266 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.444 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 8.5 ttt180 -55.13 -20.59 10.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.809 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.8 HG23 ' O ' ' A' ' 8' ' ' LEU . 4.7 p -82.59 -50.08 9.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.213 0.53 . . . . 0.0 109.596 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.8 t -65.71 -35.03 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.35 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.553 HG23 ' HB3' ' A' ' 18' ' ' ASN . 34.4 mm -77.02 -41.68 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.175 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.457 ' HA ' HD12 ' A' ' 19' ' ' LEU . . . -82.34 0.7 40.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.618 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.1 -19.25 4.38 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.922 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -147.63 13.79 1.06 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.838 0.319 . . . . 0.0 111.769 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.553 ' HB3' HG23 ' A' ' 14' ' ' ILE . 5.6 t30 -136.11 4.9 3.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.578 0.228 . . . . 0.0 111.505 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 15' ' ' ALA . 5.4 mt -94.85 -30.08 14.38 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.948 0.404 . . . . 0.0 110.586 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -124.31 -49.91 1.79 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.692 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -59.5 -43.65 93.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.059 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.409 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . . . -73.19 -53.72 10.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.242 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.4 mm -50.7 -55.74 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.178 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.6 mttp -55.73 -25.05 38.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.224 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.06 41.1 1.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.891 0.377 . . . . 0.0 110.927 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.881 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.748 0.309 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 3' ' ' LYS . 20.2 t -116.68 159.37 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.043 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.47 ' N ' HG12 ' A' ' 2' ' ' VAL . 17.0 mtpt -58.67 151.94 19.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.884 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.49 115.14 27.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.945 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.5 -59.71 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.039 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.515 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 2.3 m0 -77.12 121.87 85.36 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.608 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 6' ' ' TRP . 7.5 Cg_exo -73.71 -40.51 1.43 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.739 2.293 . . . . 0.0 113.614 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.17 -36.55 8.9 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.515 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 20.6 t -55.68 -56.96 9.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.851 0.358 . . . . 0.0 111.272 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.441 HG12 ' HB2' ' A' ' 6' ' ' TRP . 36.8 mm -54.56 -43.67 65.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.915 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.64 -20.33 13.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.492 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.6 m -80.55 -53.14 6.84 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.5 t -62.01 -35.2 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.169 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.3 mm -74.98 -38.22 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.095 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.07 -17.47 62.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.389 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -115.07 13.41 19.49 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.756 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -114.28 -69.6 0.85 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.973 0.416 . . . . 0.0 110.989 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.436 ' HA ' ' CB ' ' A' ' 22' ' ' ALA . 46.5 t30 -72.47 -9.95 59.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.563 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 87.7 mt -104.71 24.02 12.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.002 0.43 . . . . 0.0 110.811 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -170.0 -59.96 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.304 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -64.56 -39.67 94.18 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.793 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.436 ' CB ' ' HA ' ' A' ' 18' ' ' ASN . . . -76.66 -44.2 34.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.6 mt -51.46 -54.73 10.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.115 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.2 pttm -55.08 -31.41 61.16 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.101 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -71.7 -33.42 68.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.964 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.0 pttt . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.921 179.924 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.744 0.307 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.504 ' O ' HG23 ' A' ' 2' ' ' VAL . 12.4 m -98.27 84.91 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.009 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.6 ptmm? -116.33 148.18 40.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.968 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -169.07 143.16 2.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.809 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.416 HG12 ' HD1' ' A' ' 6' ' ' TRP . 21.4 t -129.9 -62.99 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.251 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.823 ' O ' HD12 ' A' ' 10' ' ' ILE . 2.9 m0 -90.87 110.33 41.04 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.798 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -73.64 -39.82 1.76 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.894 2.396 . . . . 0.0 113.599 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.77 -38.68 9.38 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.481 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 21.0 t -53.89 -61.98 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.872 0.367 . . . . 0.0 111.259 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.823 HD12 ' O ' ' A' ' 6' ' ' TRP . 19.1 mt -55.51 -40.01 56.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.986 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.635 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -57.88 -18.83 25.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.274 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.6 m -81.79 -51.51 8.07 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 39.5 t -59.94 -34.86 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.044 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.823 HD11 HG22 ' A' ' 10' ' ' ILE . 45.2 mt -64.35 -44.7 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.882 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.494 ' O ' HD12 ' A' ' 19' ' ' LEU . . . -58.27 -31.92 67.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.924 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.35 -4.53 64.25 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.775 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -106.03 -37.53 6.6 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.887 0.375 . . . . 0.0 110.726 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.522 ' ND2' HG22 ' A' ' 14' ' ' ILE . 55.9 p30 -83.59 7.6 16.78 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.539 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.985 HD22 HD11 ' A' ' 23' ' ' ILE . 7.5 mt -104.6 -55.88 2.27 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.848 0.356 . . . . 0.0 110.534 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -56.53 -60.39 3.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.537 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.9 ttm180 -58.76 -52.11 67.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.059 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -58.47 -59.15 5.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.182 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.985 HD11 HD22 ' A' ' 19' ' ' LEU . 66.9 mt -51.44 -45.42 34.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.897 0.379 . . . . 0.0 110.954 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.24 -33.84 65.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.933 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.5 tttm -68.75 98.96 0.96 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.148 -0.929 . . . . 0.0 110.926 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.83 0.348 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.46 -51.11 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.106 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.4 tttp 59.78 78.56 0.27 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.782 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -102.07 160.05 14.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.954 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.473 HG12 ' H ' ' A' ' 6' ' ' TRP . 0.2 OUTLIER -94.36 -170.78 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.679 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.639 ' O ' HD12 ' A' ' 10' ' ' ILE . 2.1 m0 -70.55 110.16 6.43 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.7 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -72.41 -39.6 2.72 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.724 2.283 . . . . 0.0 113.807 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.74 -37.14 8.85 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.472 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 22.9 t -55.47 -58.23 5.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.867 0.365 . . . . 0.0 111.268 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.948 HG22 HD11 ' A' ' 14' ' ' ILE . 15.6 mt -64.01 -40.82 90.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.204 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -57.25 -21.06 31.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.613 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.15 -48.22 10.07 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.9 t -61.03 -34.1 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.997 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.948 HD11 HG22 ' A' ' 10' ' ' ILE . 43.2 mt -70.97 -39.72 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.135 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.26 3.96 40.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.664 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -133.76 -10.85 1.75 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.594 -0.813 . . . . 0.0 113.297 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -128.09 -31.63 2.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.012 0.406 . . . . 0.0 111.463 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.507 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 33.5 m-20 -90.39 19.8 4.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.419 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.64 -21.22 30.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.811 0.339 . . . . 0.0 110.799 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -127.51 -54.91 1.34 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.651 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.68 -42.23 78.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.334 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -77.98 -50.54 11.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.289 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.5 mm -50.17 -52.54 14.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.421 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.1 pttm -53.39 -33.03 52.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.063 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -88.58 98.37 11.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.815 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.8 mttt . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.887 -179.966 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 4.1 mtp85 . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.938 0.399 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.613 HG22 ' H ' ' A' ' 4' ' ' ARG . 10.9 p -176.41 138.51 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.067 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -125.67 30.57 5.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.941 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.613 ' H ' HG22 ' A' ' 2' ' ' VAL . 27.3 mtp180 63.03 143.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.117 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.414 HG12 ' H ' ' A' ' 6' ' ' TRP . 0.2 OUTLIER -103.22 -163.5 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.544 179.767 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.448 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 5.3 m0 -55.37 146.09 44.33 Favored Pre-proline 0 C--N 1.333 -0.151 0 CA-C-O 120.599 0.238 . . . . 0.0 110.69 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.841 ' HG2' HD23 ' A' ' 8' ' ' LEU . 68.6 Cg_endo -87.04 -58.53 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.659 2.239 . . . . 0.0 113.751 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.907 ' O ' HG23 ' A' ' 12' ' ' THR . 0.5 OUTLIER -95.78 -33.49 12.25 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.71 0.29 . . . . 0.0 111.428 -179.147 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.448 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 22.0 t -49.31 -53.07 9.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.895 0.378 . . . . 0.0 111.536 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.426 HG22 ' CG1' ' A' ' 14' ' ' ILE . 29.7 mm -71.44 -46.41 64.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.082 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.6 tpt85 -51.71 -22.91 3.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.663 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.907 HG23 ' O ' ' A' ' 8' ' ' LEU . 43.2 p -81.31 -50.52 9.41 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.1 t -63.41 -35.23 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.123 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.426 ' CG1' HG22 ' A' ' 10' ' ' ILE . 32.1 mm -68.33 -43.89 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.017 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.51 -11.77 61.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.663 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -109.51 -13.62 16.43 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.04 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.6 -35.9 3.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.875 0.338 . . . . 0.0 111.275 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.44 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 8.3 m-20 -94.74 21.23 7.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.274 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.701 HD12 ' N ' ' A' ' 20' ' ' TYR . 0.3 OUTLIER -87.13 -17.49 32.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.869 179.715 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.701 ' N ' HD12 ' A' ' 19' ' ' LEU . 10.7 t80 -131.84 -51.05 0.97 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.584 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -58.24 -43.5 87.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.857 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -77.93 -50.85 11.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.186 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.4 mm -50.48 -47.34 27.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.268 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.0 mmtm -53.89 -32.76 54.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.077 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -107.78 51.02 0.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.906 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.148 -0.929 . . . . 0.0 110.84 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.803 0.335 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.9 m -131.62 144.86 36.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.072 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.8 mttm -161.08 133.88 6.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.963 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 -106.51 -70.99 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.678 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.857 HG12 ' CD1' ' A' ' 6' ' ' TRP . 3.3 t -149.45 -73.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.857 ' CD1' HG12 ' A' ' 5' ' ' VAL . 3.5 m0 -111.04 99.31 42.54 Favored Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.53 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -64.9 -35.81 42.39 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.988 2.459 . . . . 0.0 113.798 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.84 -38.73 8.93 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.527 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 42.0 t -55.72 -59.55 2.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.927 0.394 . . . . 0.0 111.26 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.895 HG22 HD11 ' A' ' 14' ' ' ILE . 42.4 mm -54.42 -38.62 41.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.191 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.457 ' HA ' HD12 ' A' ' 14' ' ' ILE . 16.1 ttp-105 -55.97 -19.28 11.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.576 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.6 p -82.18 -51.34 8.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.334 0.587 . . . . 0.0 109.547 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.4 t -61.51 -34.99 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.286 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.895 HD11 HG22 ' A' ' 10' ' ' ILE . 46.8 mt -66.29 -38.46 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.016 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.26 -3.83 44.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.574 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -139.96 19.95 2.89 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.941 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -155.41 -33.98 0.09 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.576 0.227 . . . . 0.0 111.481 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.466 ' HB2' HG23 ' A' ' 14' ' ' ILE . 3.4 m-20 -87.08 16.42 5.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.598 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.739 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.9 OUTLIER -88.49 -19.56 26.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.854 0.359 . . . . 0.0 110.785 179.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.511 ' CD2' HD12 ' A' ' 19' ' ' LEU . 10.7 m-85 -129.48 -50.2 1.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.494 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.58 -45.34 94.53 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.28 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -72.75 -53.43 11.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.231 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.739 HD12 ' O ' ' A' ' 19' ' ' LEU . 28.8 mt -53.83 -38.66 36.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.997 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.3 mmtm -57.19 -35.76 69.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.954 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -69.74 92.11 0.66 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.936 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.2 mttp . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.955 -179.999 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.78 0.324 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.496 HG13 ' N ' ' A' ' 3' ' ' LYS . 12.2 p -136.49 -45.15 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.157 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.496 ' N ' HG13 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -74.12 -178.16 3.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.908 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -88.17 85.74 6.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.825 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.8 t -141.15 156.49 21.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.959 0.409 . . . . 0.0 111.137 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.531 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 0.6 OUTLIER -112.48 107.36 55.25 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.595 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.53 -37.97 15.66 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.871 2.381 . . . . 0.0 113.938 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.42 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.6 OUTLIER -102.99 -35.72 8.46 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.519 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.531 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 38.4 t -56.59 -51.39 66.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.86 0.362 . . . . 0.0 111.267 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.447 HG22 ' CG1' ' A' ' 14' ' ' ILE . 50.7 mm -57.97 -49.18 82.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.157 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.3 ttt-85 -52.92 -22.32 5.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.459 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.2 m -82.12 -49.89 9.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.316 0.579 . . . . 0.0 109.497 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.9 t -64.63 -35.43 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.234 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.447 ' CG1' HG22 ' A' ' 10' ' ' ILE . 27.4 mm -64.92 -39.43 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.842 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.04 -21.98 66.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.238 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.802 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -107.57 8.48 37.41 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.895 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -121.45 -37.94 2.84 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.832 0.349 . . . . 0.0 111.212 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.615 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 2.5 m-80 -95.15 20.1 9.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.393 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.802 HD23 ' HA2' ' A' ' 16' ' ' GLY . 3.3 pp -90.32 -22.94 21.29 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.838 0.351 . . . . 0.0 110.679 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -121.81 -54.39 1.94 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.518 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -48.39 81.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.268 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -65.99 -56.06 13.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.357 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.653 HD12 ' O ' ' A' ' 19' ' ' LEU . 16.6 mt -53.13 -48.29 53.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.907 0.384 . . . . 0.0 111.174 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -33.25 67.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.026 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.24 -36.12 79.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.903 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.2 mmmt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.898 -179.98 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 CA-C-O 120.85 0.357 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.495 HG22 ' N ' ' A' ' 3' ' ' LYS . 11.9 p -91.76 158.97 2.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.08 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.495 ' N ' HG22 ' A' ' 2' ' ' VAL . 0.2 OUTLIER 66.66 92.59 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 62.17 116.77 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.986 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.676 HG12 ' CD1' ' A' ' 6' ' ' TRP . 5.0 t -99.46 -67.93 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.913 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.676 ' CD1' HG12 ' A' ' 5' ' ' VAL . 1.0 OUTLIER -103.73 145.62 30.97 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.587 179.776 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.434 ' HG2' HD23 ' A' ' 8' ' ' LEU . 70.4 Cg_endo -89.16 -58.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.598 2.199 . . . . 0.0 113.775 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.434 HD23 ' HG2' ' A' ' 7' ' ' PRO . 0.7 OUTLIER -93.15 -30.63 15.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.74 0.305 . . . . 0.0 111.392 -178.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.455 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 16.9 t -52.9 -59.15 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.265 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.425 HG12 ' HB2' ' A' ' 6' ' ' TRP . 28.7 mm -58.65 -48.55 85.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.994 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.23 -18.66 4.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.558 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.1 m -82.72 -49.36 9.85 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.406 ' O ' ' HB2' ' A' ' 17' ' ' TYR . 25.1 t -62.96 -36.24 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.052 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 72.2 mt -61.8 -38.85 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.474 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . . . -62.8 -22.33 66.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.145 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -114.49 -2.65 22.8 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.231 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.422 ' HA ' ' HB2' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -127.16 1.6 6.46 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.995 0.397 . . . . 0.0 111.636 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.423 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.9 t-20 -142.04 -43.29 0.34 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.646 0.26 . . . . 0.0 111.423 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.41 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 4.3 mt -92.54 18.58 8.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.787 0.327 . . . . 0.0 110.994 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -157.07 -55.34 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.11 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.422 ' HB2' ' HA ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -70.17 -45.6 66.38 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.754 179.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -75.26 -38.11 60.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.09 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.2 mm -52.37 -56.31 7.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.323 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.9 mmtm -51.92 -33.61 38.01 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.081 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -78.93 95.97 5.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.903 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.6 mtm105 . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.812 0.339 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.4 t 61.92 80.7 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.193 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.0 118.23 0.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.787 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.02 155.19 46.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.917 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.456 HG12 ' H ' ' A' ' 6' ' ' TRP . 0.2 OUTLIER -90.2 -163.9 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.374 179.776 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.513 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 1.1 m0 -108.99 99.75 36.84 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 120.75 0.31 . . . . 0.0 110.706 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.85 -36.61 13.16 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.019 2.479 . . . . 0.0 113.582 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.77 -41.55 9.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.721 0.296 . . . . 0.0 111.485 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.513 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 39.7 t -52.7 -66.11 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.093 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.625 HG22 HD11 ' A' ' 14' ' ' ILE . 36.1 mm -55.98 -30.49 28.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.013 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.517 ' HA ' HD12 ' A' ' 14' ' ' ILE . 4.3 ttm-85 -54.39 -20.8 8.07 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.641 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.431 ' CG2' ' N ' ' A' ' 13' ' ' VAL . 1.3 t -82.51 -47.15 12.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.175 0.512 . . . . 0.0 109.714 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.431 ' N ' ' CG2' ' A' ' 12' ' ' THR . 26.4 t -62.64 -34.33 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.783 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.625 HD11 HG22 ' A' ' 10' ' ' ILE . 27.7 mt -70.55 -53.57 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.098 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.4 -25.88 68.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.259 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.723 ' HA2' HD23 ' A' ' 19' ' ' LEU . . . -90.29 -8.12 66.73 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.955 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -115.06 -35.7 4.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.853 0.358 . . . . 0.0 111.125 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.601 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 6.8 m-20 -81.52 0.37 38.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.628 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.723 HD23 ' HA2' ' A' ' 16' ' ' GLY . 3.8 pp -77.91 -21.24 51.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.853 0.358 . . . . 0.0 110.871 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -128.46 -51.89 1.27 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.956 0.407 . . . . 0.0 110.593 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.39 -42.72 87.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.065 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -78.64 -51.03 10.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.217 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.5 mm -49.91 -55.16 5.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.33 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -53.54 -30.21 40.58 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.158 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.3 ttpp -91.34 49.89 1.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.1 mttt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.914 179.95 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.891 0.377 . . . . 0.0 111.173 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 2' ' ' VAL . 9.0 p -138.1 105.3 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.19 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -77.87 149.28 34.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.851 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.38 122.59 45.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.063 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.467 HG12 ' H ' ' A' ' 6' ' ' TRP . 0.2 OUTLIER -92.01 -167.76 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.546 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.652 ' O ' HD12 ' A' ' 10' ' ' ILE . 3.6 m0 -77.73 129.28 77.07 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.648 0.261 . . . . 0.0 110.607 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.787 ' HG2' HD23 ' A' ' 8' ' ' LEU . 66.4 Cg_endo -86.33 -57.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.684 2.256 . . . . 0.0 113.85 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.787 HD23 ' HG2' ' A' ' 7' ' ' PRO . 0.3 OUTLIER -89.56 -30.7 18.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.814 0.34 . . . . 0.0 111.278 -178.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 6' ' ' TRP . 12.8 t -55.39 -65.84 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.652 HD12 ' O ' ' A' ' 6' ' ' TRP . 15.0 mt -59.21 -37.8 70.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.985 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.93 -22.28 3.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.588 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.611 HG23 ' O ' ' A' ' 8' ' ' LEU . 18.2 p -78.46 -54.27 6.35 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.9 t -61.24 -34.99 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.11 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.613 ' CG1' HG22 ' A' ' 10' ' ' ILE . 29.8 mm -68.49 -39.07 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.925 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.43 ' O ' HD12 ' A' ' 19' ' ' LEU . . . -80.25 -6.8 58.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.512 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -121.13 -7.55 8.4 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.045 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -143.44 10.83 1.68 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.887 0.344 . . . . 0.0 111.642 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.575 ' HA ' ' HB2' ' A' ' 22' ' ' ALA . 3.5 t-20 -137.28 8.75 2.93 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.667 0.27 . . . . 0.0 111.407 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.466 ' HA ' HD23 ' A' ' 19' ' ' LEU . 13.4 mt -101.28 -32.87 10.29 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.937 0.398 . . . . 0.0 110.427 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -120.53 -49.14 2.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.252 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -48.63 80.94 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.874 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.575 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . . . -59.94 -45.9 91.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.062 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.9 mm -51.4 -41.58 26.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.221 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.4 mtpt -54.16 -34.21 59.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.067 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -77.97 64.2 3.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.849 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.4 mttt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.862 -179.977 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.852 0.358 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.4 m -96.38 -179.6 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.117 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -148.33 122.2 9.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.777 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -58.04 -62.28 1.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.892 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 t -85.38 153.36 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.745 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.48 ' CB ' ' HB ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -118.04 82.85 18.17 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.741 -179.744 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -63.48 -35.57 59.68 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 123.053 2.502 . . . . 0.0 113.442 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 pp -94.19 -42.2 9.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.901 0.381 . . . . 0.0 111.386 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.48 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 19.5 t -54.3 -59.65 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.091 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.417 HG22 ' CD1' ' A' ' 14' ' ' ILE . 62.9 mt -56.03 -40.73 65.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.972 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.46 -18.33 27.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.374 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.7 m -82.36 -51.55 7.76 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.7 t -58.65 -34.59 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.94 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.417 ' CD1' HG22 ' A' ' 10' ' ' ILE . 97.1 mt -68.73 -53.7 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.847 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.483 ' O ' HD12 ' A' ' 19' ' ' LEU . . . -61.75 -20.76 63.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.325 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.7 -20.78 53.15 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.989 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.6 -38.9 5.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.847 0.356 . . . . 0.0 111.192 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.646 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 3.5 m120 -66.61 -25.7 66.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.028 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 15' ' ' ALA . 10.1 mt -58.09 -19.92 35.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.252 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -114.82 -62.29 1.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.921 0.391 . . . . 0.0 110.814 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -49.54 75.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.441 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -72.41 -52.5 15.67 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.391 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.5 mm -54.85 -53.17 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.972 0.415 . . . . 0.0 111.1 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.92 -29.13 62.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.04 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.3 mmtt -85.76 85.57 7.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.904 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.0 tttt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.875 179.966 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.773 0.321 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -117.22 -38.78 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.165 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.99 -172.68 4.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.899 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.12 149.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.974 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.55 -62.87 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.159 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.467 ' CE3' ' CG1' ' A' ' 9' ' ' VAL . 2.8 m0 -69.34 149.57 97.31 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.821 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -89.73 -57.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.812 2.341 . . . . 0.0 113.885 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.1 pp -92.48 -31.53 15.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.746 0.308 . . . . 0.0 111.469 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.467 ' CG1' ' CE3' ' A' ' 6' ' ' TRP . 18.5 t -53.22 -60.19 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.314 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.705 HG22 HD11 ' A' ' 14' ' ' ILE . 36.5 mm -63.89 -34.95 71.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.795 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.527 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.2 OUTLIER -54.57 -20.12 7.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.421 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -80.67 -52.0 8.05 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.2 t -59.03 -34.69 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.084 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.705 HD11 HG22 ' A' ' 10' ' ' ILE . 30.9 mt -70.01 -40.08 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.84 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.541 ' O ' HD12 ' A' ' 19' ' ' LEU . . . -63.53 -33.7 76.16 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.034 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.02 -8.51 78.85 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.698 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.443 ' CE2' ' HD3' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -98.31 -65.66 0.95 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.927 0.394 . . . . 0.0 110.974 -179.903 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 5.5 t30 -55.0 -23.35 18.9 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.486 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.541 HD12 ' O ' ' A' ' 15' ' ' ALA . 59.9 mt -85.38 -25.36 27.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.217 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.5 27.18 7.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.957 0.408 . . . . 0.0 111.077 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.443 ' HD3' ' CE2' ' A' ' 17' ' ' TYR . 16.1 ttp85 -146.69 -48.18 0.19 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.267 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -80.77 -34.4 34.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.113 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.5 mm -57.26 -57.55 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.002 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.72 -30.63 33.41 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.139 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.05 93.51 5.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.88 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.9 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.826 0.346 . . . . 0.0 111.162 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.46 HG23 ' N ' ' A' ' 3' ' ' LYS . 21.4 m -132.84 -44.87 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.159 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.487 ' HE2' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER 64.09 122.5 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.816 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 34.2 mtp180 -143.2 92.61 2.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.976 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.487 HG22 ' HE2' ' A' ' 3' ' ' LYS . 3.4 t -71.61 155.97 7.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.948 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.478 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 0.9 OUTLIER -111.25 123.3 35.46 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.609 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.78 ' HG2' HD23 ' A' ' 8' ' ' LEU . 65.1 Cg_endo -83.14 -57.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.578 2.185 . . . . 0.0 114.067 -178.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 12' ' ' THR . 0.7 OUTLIER -88.76 -31.22 18.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.761 0.315 . . . . 0.0 111.351 -178.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 6' ' ' TRP . 18.8 t -52.92 -65.77 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.319 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.1 mt -56.9 -41.03 75.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.236 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.65 -21.3 10.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.7 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.818 HG23 ' O ' ' A' ' 8' ' ' LEU . 6.1 p -83.54 -48.25 10.46 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.8 t -62.95 -35.0 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.155 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.8 mm -76.17 -38.59 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.087 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.72 ' O ' HD12 ' A' ' 19' ' ' LEU . . . -75.05 -13.97 60.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.44 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.75 -23.19 8.89 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.774 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -97.73 -44.12 6.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.829 0.347 . . . . 0.0 110.997 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.568 ' HA ' ' HB2' ' A' ' 22' ' ' ALA . 48.3 t30 -75.2 -7.24 53.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.47 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.72 HD12 ' O ' ' A' ' 15' ' ' ALA . 16.1 mt -101.63 -26.6 13.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.859 0.361 . . . . 0.0 110.63 179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.87 -55.69 2.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.555 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -48.77 80.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.134 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.568 ' HB2' ' HA ' ' A' ' 18' ' ' ASN . . . -60.08 -48.45 81.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.256 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.1 mm -51.47 -48.12 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.239 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.07 -33.3 51.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.182 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -84.75 -32.79 23.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.6 mttm . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.299 -0.858 . . . . 0.0 110.875 -179.868 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.922 0.391 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.4 t -119.25 110.99 31.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.112 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 68.68 -67.38 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.995 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -110.95 156.15 21.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.944 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.4 t -73.12 -60.92 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.118 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.818 ' O ' HD12 ' A' ' 10' ' ' ILE . 1.4 m0 -86.68 110.86 35.56 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.699 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.62 -40.27 1.57 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.815 2.343 . . . . 0.0 113.687 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.577 ' O ' HG23 ' A' ' 12' ' ' THR . 0.4 OUTLIER -98.12 -37.76 9.59 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -178.776 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.486 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 19.3 t -54.47 -61.46 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.873 0.368 . . . . 0.0 111.423 -179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.818 HD12 ' O ' ' A' ' 6' ' ' TRP . 16.1 mt -57.39 -38.57 63.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.129 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -19.53 10.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.518 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 8' ' ' LEU . 14.2 p -83.28 -49.86 8.97 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.9 t -60.94 -34.72 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.267 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.547 ' CD1' HG22 ' A' ' 10' ' ' ILE . 96.2 mt -66.57 -39.86 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.962 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.551 ' O ' HD12 ' A' ' 19' ' ' LEU . . . -82.0 -0.29 43.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.572 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.25 -13.44 7.61 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.826 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -107.68 -39.67 5.53 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.766 0.317 . . . . 0.0 110.862 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.653 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 5.3 m120 -61.28 -28.2 69.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.855 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.551 HD12 ' O ' ' A' ' 15' ' ' ALA . 7.9 mt -59.45 -19.66 49.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.065 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -125.71 -55.72 1.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.727 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.14 -33.88 69.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.419 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -91.36 -47.68 7.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.335 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.9 mm -55.86 -40.12 60.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.963 0.411 . . . . 0.0 111.104 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -56.14 -34.83 66.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.023 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.7 mtpp -99.89 33.47 2.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.946 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 29.5 ptt85 . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.875 0.369 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.3 t -60.77 149.49 7.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.15 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.1 mmtp -104.32 177.47 4.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.752 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.62 -73.19 0.61 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.916 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.688 HG12 ' CD1' ' A' ' 6' ' ' TRP . 5.6 t -151.99 -65.46 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.089 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.784 ' O ' HD12 ' A' ' 10' ' ' ILE . 1.8 m0 -105.65 104.33 47.92 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.664 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -70.88 -38.85 4.87 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.884 2.389 . . . . 0.0 113.775 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.444 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -98.57 -37.91 9.36 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -178.695 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.473 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 21.3 t -54.15 -61.39 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.999 0.428 . . . . 0.0 111.235 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.784 HD12 ' O ' ' A' ' 6' ' ' TRP . 18.8 mt -55.57 -41.33 63.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.002 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.9 ttt85 -59.28 -17.44 28.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.301 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.28 -50.04 8.79 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.424 HG13 ' HD2' ' A' ' 17' ' ' TYR . 39.4 t -59.9 -34.85 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.982 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 68.3 mt -77.89 -37.58 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.927 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.84 9.7 18.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.456 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.491 ' HA2' HD11 ' A' ' 19' ' ' LEU . . . -133.52 -11.92 1.65 Allowed Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.56 -0.829 . . . . 0.0 113.311 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.424 ' HD2' HG13 ' A' ' 13' ' ' VAL . 14.9 m-85 -128.96 -26.96 2.57 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 117.113 0.457 . . . . 0.0 111.437 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.603 ' CG ' ' HB2' ' A' ' 22' ' ' ALA . 0.6 OUTLIER -88.9 15.14 8.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.342 -179.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.491 HD11 ' HA2' ' A' ' 16' ' ' GLY . 2.4 mt -84.15 -30.69 25.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.95 0.405 . . . . 0.0 110.597 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -118.39 -52.02 2.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.587 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.42 -48.64 74.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.134 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.603 ' HB2' ' CG ' ' A' ' 18' ' ' ASN . . . -70.6 -53.91 14.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.936 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.0 mm -53.72 -44.79 60.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.095 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -56.73 -35.5 68.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.002 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.43 96.83 10.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.944 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.8 ttpt . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.997 179.936 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.843 0.354 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.4 t -117.13 102.5 13.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.138 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -115.51 163.77 15.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.751 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -168.16 107.88 0.53 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.047 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 6' ' ' TRP . 1.3 t -83.87 174.19 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.577 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.565 ' H ' HG12 ' A' ' 5' ' ' VAL . 2.2 m0 -80.11 132.05 61.07 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.668 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.749 ' HG2' HD23 ' A' ' 8' ' ' LEU . 66.6 Cg_endo -88.37 -57.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.679 2.253 . . . . 0.0 113.828 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.749 HD23 ' HG2' ' A' ' 7' ' ' PRO . 0.3 OUTLIER -91.02 -33.93 15.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.801 0.334 . . . . 0.0 111.28 -179.167 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.515 ' HB ' ' HB3' ' A' ' 6' ' ' TRP . 21.5 t -51.45 -62.57 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.377 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.665 HG22 HD11 ' A' ' 14' ' ' ILE . 30.5 mt -61.18 -34.54 60.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.839 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.85 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.3 OUTLIER -52.1 -21.94 3.7 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.463 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.1 m -79.29 -52.52 8.01 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.8 t -60.35 -34.63 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.951 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.85 HD12 ' HA ' ' A' ' 11' ' ' ARG . 47.1 mt -61.14 -43.45 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.799 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.487 ' O ' HD12 ' A' ' 19' ' ' LEU . . . -78.31 -0.43 28.79 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.7 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.08 -13.63 6.39 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.152 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.76 -51.75 0.74 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.86 0.33 . . . . 0.0 111.353 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.628 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 4.6 m-80 -58.41 -20.79 47.35 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.268 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.487 HD12 ' O ' ' A' ' 15' ' ' ALA . 12.3 mt -53.29 -23.22 8.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.177 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -126.1 -56.86 1.43 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.338 . . . . 0.0 110.797 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.51 -32.87 67.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.379 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -90.25 -48.38 7.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.397 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.615 HD13 ' NZ ' ' A' ' 26' ' ' LYS . 49.1 mm -53.39 -41.7 45.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.189 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.4 -31.51 61.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.029 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -108.64 30.82 6.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.994 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.615 ' NZ ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.913 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 9.4 mtt180 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.982 0.42 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.4 t -136.88 133.58 48.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.003 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.74 -69.74 0.29 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.074 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 14.2 mmt85 56.55 65.08 1.5 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.92 0.391 . . . . 0.0 110.804 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.683 HG12 ' CD1' ' A' ' 6' ' ' TRP . 18.5 t -83.92 -66.58 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.331 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.683 ' CD1' HG12 ' A' ' 5' ' ' VAL . 3.8 m0 -97.48 134.41 22.59 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.895 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.516 ' HG2' HD23 ' A' ' 8' ' ' LEU . 68.2 Cg_endo -90.2 -57.22 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.792 2.328 . . . . 0.0 113.721 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.516 HD23 ' HG2' ' A' ' 7' ' ' PRO . 0.7 OUTLIER -89.12 -31.87 17.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.822 0.344 . . . . 0.0 111.308 -179.125 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.45 ' HB ' ' HB3' ' A' ' 6' ' ' TRP . 17.6 t -52.86 -65.59 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.282 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.869 HG22 HD11 ' A' ' 14' ' ' ILE . 19.5 mt -59.49 -38.31 74.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.15 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.576 ' HA ' HD12 ' A' ' 14' ' ' ILE . 1.6 tpm_? -55.85 -19.85 13.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.505 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.8 m -81.16 -51.92 7.91 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.8 t -59.26 -34.47 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.02 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.869 HD11 HG22 ' A' ' 10' ' ' ILE . 40.0 mt -67.78 -51.77 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.002 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.464 ' O ' HD12 ' A' ' 19' ' ' LEU . . . -64.47 -22.61 67.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.437 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.49 -9.82 64.35 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.122 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -116.29 -37.98 3.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.869 0.335 . . . . 0.0 111.192 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.765 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 2.4 m-80 -74.6 -27.2 60.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.144 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.464 HD12 ' O ' ' A' ' 15' ' ' ALA . 10.7 mt -57.9 -20.81 39.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.304 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.424 ' CZ ' ' HE3' ' A' ' 24' ' ' LYS . 1.5 t80 -115.99 -65.69 1.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.372 . . . . 0.0 110.913 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.73 -45.1 74.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.553 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.765 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -73.81 -53.21 10.77 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.274 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.1 mm -55.37 -50.61 64.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.007 0.432 . . . . 0.0 111.128 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.424 ' HE3' ' CZ ' ' A' ' 20' ' ' TYR . 24.6 mmtt -58.21 -30.48 66.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.069 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -60.0 -65.55 0.66 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.1 mtmm . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.89 -179.973 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.775 ' HG3' HG23 ' A' ' 2' ' ' VAL . 1.9 ptt180 . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.832 0.349 . . . . 0.0 111.286 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.775 HG23 ' HG3' ' A' ' 1' ' ' ARG . 21.4 t 63.67 97.83 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.23 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.61 -65.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.919 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.507 ' HG2' HD13 ' A' ' 10' ' ' ILE . 0.0 OUTLIER 55.4 -168.39 0.09 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.963 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.0 t -90.47 -55.97 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.068 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.72 ' O ' HD12 ' A' ' 10' ' ' ILE . 1.6 m0 -80.64 114.88 51.42 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.628 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 6' ' ' TRP . 7.3 Cg_exo -73.58 -42.03 0.98 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.693 2.262 . . . . 0.0 113.748 -178.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.897 ' O ' HG23 ' A' ' 12' ' ' THR . 0.5 OUTLIER -101.64 -34.91 9.3 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.702 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.486 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 20.2 t -54.04 -55.21 15.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.974 0.416 . . . . 0.0 111.447 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.72 HD12 ' O ' ' A' ' 6' ' ' TRP . 10.9 mt -68.91 -44.81 81.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.27 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.526 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -53.52 -22.47 8.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.859 -179.415 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.897 HG23 ' O ' ' A' ' 8' ' ' LEU . 50.8 p -82.38 -49.58 9.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.475 HG12 ' HD2' ' A' ' 17' ' ' TYR . 21.4 t -64.38 -35.13 73.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.113 178.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.526 ' CG1' HG22 ' A' ' 10' ' ' ILE . 36.3 mm -78.01 -37.5 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.101 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.703 ' HA ' HD12 ' A' ' 19' ' ' LEU . . . -61.5 -23.04 65.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.509 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.85 -7.52 29.19 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.602 -0.809 . . . . 0.0 113.313 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.475 ' HD2' HG12 ' A' ' 13' ' ' VAL . 10.3 m-85 -115.85 -22.09 9.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.904 0.352 . . . . 0.0 111.574 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -117.74 -28.87 5.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.577 0.227 . . . . 0.0 111.367 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.703 HD12 ' HA ' ' A' ' 15' ' ' ALA . 5.9 mt -97.84 25.85 5.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.879 0.371 . . . . 0.0 110.675 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -163.34 -59.88 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.224 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -43.3 74.93 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.995 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.94 -49.27 25.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.246 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.422 HD11 ' HA ' ' A' ' 19' ' ' LEU . 35.3 mt -51.51 -59.97 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.009 0.433 . . . . 0.0 111.131 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -53.46 -25.31 15.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.171 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -93.19 44.6 1.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.937 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.013 179.969 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.804 0.335 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.8 m -99.17 125.82 52.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.076 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -152.8 -46.46 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 68.4 mtm180 -140.54 109.94 6.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.026 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.483 HG12 ' CD1' ' A' ' 6' ' ' TRP . 21.9 t -110.81 -65.22 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.011 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.483 ' CD1' HG12 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -93.49 147.29 33.41 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.695 179.812 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.823 ' HG2' HD23 ' A' ' 8' ' ' LEU . 70.8 Cg_endo -89.12 -58.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.783 2.322 . . . . 0.0 113.944 -179.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.823 HD23 ' HG2' ' A' ' 7' ' ' PRO . 0.4 OUTLIER -93.58 -34.02 13.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.768 0.318 . . . . 0.0 111.293 -179.039 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.456 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 39.8 t -49.79 -57.4 2.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.558 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.854 HG22 HD11 ' A' ' 14' ' ' ILE . 78.2 mt -65.74 -44.46 93.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.147 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.747 ' HA ' HD12 ' A' ' 14' ' ' ILE . 0.5 OUTLIER -51.88 -21.58 3.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.649 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.47 -50.27 9.62 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.431 HG12 ' CD1' ' A' ' 17' ' ' TYR . 36.0 t -61.91 -35.24 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.947 178.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.854 HD11 HG22 ' A' ' 10' ' ' ILE . 51.6 mt -61.25 -43.12 95.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.739 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.505 ' O ' HD12 ' A' ' 19' ' ' LEU . . . -60.38 -24.52 65.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.102 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -112.27 15.36 25.3 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.875 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.431 ' CD1' HG12 ' A' ' 13' ' ' VAL . 0.6 OUTLIER -118.89 -41.78 2.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.891 0.377 . . . . 0.0 110.963 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.554 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 20.7 t-20 -73.55 -9.24 58.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.356 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.505 HD12 ' O ' ' A' ' 15' ' ' ALA . 28.6 mt -85.06 -17.98 35.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.797 0.332 . . . . 0.0 111.325 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -123.84 -59.18 1.53 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.835 0.35 . . . . 0.0 110.81 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.67 -45.15 73.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.39 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -75.72 -52.03 11.38 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.068 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.6 mm -51.82 -41.63 30.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.172 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -55.18 -34.56 63.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.091 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -66.29 -33.08 74.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.916 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.295 -0.859 . . . . 0.0 110.871 179.959 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.819 0.342 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.7 m -76.53 149.71 6.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.15 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -113.7 -57.49 2.27 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.875 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -82.62 116.2 21.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.811 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.714 HG12 ' CD1' ' A' ' 6' ' ' TRP . 9.7 t -127.52 -65.87 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.993 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.714 ' CD1' HG12 ' A' ' 5' ' ' VAL . 1.9 m0 -104.36 141.18 22.0 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.59 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -89.54 -58.57 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.684 2.256 . . . . 0.0 113.684 -179.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.892 ' O ' HG23 ' A' ' 12' ' ' THR . 2.9 pp -93.09 -30.94 15.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.791 0.329 . . . . 0.0 111.372 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.471 ' HB ' ' CB ' ' A' ' 6' ' ' TRP . 21.3 t -50.08 -57.98 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.427 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.912 HG22 HD11 ' A' ' 14' ' ' ILE . 23.0 mt -66.55 -40.14 85.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.244 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.3 tpt85 -56.33 -20.09 17.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.653 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.892 HG23 ' O ' ' A' ' 8' ' ' LEU . 21.4 p -82.94 -49.71 9.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.347 0.594 . . . . 0.0 109.451 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.545 HG13 ' CD2' ' A' ' 17' ' ' TYR . 26.2 t -60.81 -34.64 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.138 178.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.912 HD11 HG22 ' A' ' 10' ' ' ILE . 43.5 mt -73.02 -38.15 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.265 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.477 ' O ' HD12 ' A' ' 19' ' ' LEU . . . -85.15 5.35 30.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.592 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -130.12 -22.78 1.09 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.456 -0.878 . . . . 0.0 113.238 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.545 ' CD2' HG13 ' A' ' 13' ' ' VAL . 93.0 m-85 -119.23 -30.09 5.03 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 117.035 0.417 . . . . 0.0 111.601 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.675 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 1.4 m-20 -84.34 5.56 26.48 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.477 HD12 ' O ' ' A' ' 15' ' ' ALA . 5.2 mt -79.96 -9.71 59.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.712 0.291 . . . . 0.0 111.029 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.98 -60.24 0.97 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.886 0.374 . . . . 0.0 110.634 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -43.4 83.2 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.238 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -76.27 -50.9 13.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.217 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.0 mm -47.5 -62.9 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.34 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -53.63 -30.31 42.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.013 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.68 -62.22 1.57 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.945 179.933 . . . . . . . . 1 1 . 1 stop_ save_